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ABSTRACT 
PROGRAMMING MICROENVIRONMENTAL SIGNALS WITH BIOACTIVE 
PEPTIDE AMPHIPHILES FOR SKELETAL AND CARDIAC MYOGENESIS 
 
İmmihan Ceren Garip 
M.S. in Materials Science and Nanotechnology 
Supervisor: Assist. Prof. Dr. Ayşe Begüm Tekinay 
August, 2014 
 
The extracellular matrix (ECM) is crucial for the coordination and regulation of 
various cellular processes, including cell adhesion, recruitment, differentiation and 
death. ECM components structurally support tissue function and regeneration by 
acting as a substrate for cell migration and differentiation. In addition, by facilitating 
the fine localization of signals within their structural framework, these components 
activate receptors on the cell membrane for the initiation of signal transduction 
cascades. As such, cell-matrix interactions and matrix-associated signals are 
important for the normal functioning of cells, as well as for natural or artificially 
assisted tissue regeneration. In keeping with this ECM-centric approach, we designed 
and synthesized peptide amphiphiles with bioactive epitopes to resemble the native 
microenvironment of muscle tissue and to examined their potential in the induction 
of progenitor cell differentiation into skeletal myotubes and cardiac myocytes. The 
formation of skeletal myotubes was promoted through the use of basal lamina-
mimetic peptide nanofibers inspired by the chemical structures of laminin and 
fibronectin, two proteins strongly represented in the skeletal muscle extracellular 
matrix. We demonstrated that our basal lamina mimetic peptide nanofiber system 
actively interacts with the cells it contains and enhances their differentiation within 3 
days. Morphological analysis and immunocytochemical stainings indicated the 
formation of differentiated myotubes.  
ii 
 
We also designed glycosaminoglycan-mimetic peptide amphiphiles to mimic the 
glycosaminoglycans found in the myocardium. Glycosaminoglycans have been 
reported to play substantial roles in growth factor binding and the induction of 
angiogenesis, and their mimicry through peptide amphiphile nanofibers is promising 
as a combined approach for generating multifunctional cardiovascular tissue 
engineering scaffolds. We demonstrated that peptide nanofibers enhance the 
adhesion of cells to the surface and induce cardiac myoblast cells to differentiate into 
cardiomyocytes through both gene expression analysis and immunostainings.  
In summary, myogenic platforms were developed by programming signal rich 
environment from self-assembled peptide nanofibers inspired from the components 
of the ECM to induce the differentiation of cells. These bioactive nanofiber systems 
serve as promising platforms for muscle tissue engineering applications.  
 
Keywords: Peptide nanofibers, extracellular matrix, biomimetic, basal lamina, 
skeletal muscle tissue, laminin, fibronectin, glycosaminoglycan, myocardial 
regeneration.  
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ÖZET 
BİYOAKTİF PEPTİT AMFİFİLLER İLE ÇİZGİLİ KAS VE KALP KASI 
OLUŞUMU İÇİN MİKROÇEVRESEL SİNYALLERİ PROGRAMLAMA 
İmmihan Ceren Garip 
Malzeme Bilimi ve Nanoteknoloji Programı, Yüksek Lisans 
Tez Yöneticisi: Yrd. Doç. Dr. Ayşe Begüm Tekinay 
Ağustos, 2014 
 
Hücrelerarası ekstrasellüler matris, hücre yapışması, hareketi, farklılaşması ve ölümü 
gibi hücresel olaylarda önemli düzenleyici ve yönlendirici roller oynamaktadır. 
Dokunun görevini yerine getirebilmesi ve yenilenebilmesi için, matris elemanları, 
hücrelere yapısal olarak destek olmakla birlikte, hücrelerin hareket edip 
farklılaşmalarını sağlayacak yüzey görevi de görmektedirler. Ayrıca, hücrelerde 
tepki oluşturacak sinyallerin düzgün bir şekilde hücrelere sunulmasını sağlayarak, 
reseptörlerin aktive edilip sinyal iletiminin sağlanmasında rol alırlar. Bu nedenle 
hücre-matris etkileşimi ve matrise bağlı sinyaller hücrelerin normal fonksiyonlarını 
yerine getirmelerinin yanı sıra dokunun yenilenmesinde de önemlidir. Bu tezde, kas 
dokusunun doğal çevresini taklit eden biyoaktif peptit nanofiberler tasarlanarak, 
öncül hücrelerin çizgili kas ve kalp kası hücrelerine dönüşmelerindeki etkileri 
araştırılmıştır.  İlk olarak, çizgili kas oluşumunu indüklemek için, çizgili kas 
hücrelerarası matrisinde bulunan laminin ve fibronectin proteinlerinin kimyasal 
yapılarından esinlenerek, bazal laminayı taklit eden peptit nanofiberler tasarlanmıştır. 
Bu peptit nanofiber sisteminin hücrelerle etkileştiği ve üç gün içerisinde 
farklılaşmayı arttırdığı gösterilmiştir. Morfolojik ve immunojenik boyamalar 
farklılaşmış myotüplerin oluştuğunu göstermiştir.  
Ayrıca, kalp dokusunun hücrelerarası iskele yapısında bulunan 
glikozaminoglikanların kimyasal yapıları kullanılarak glikozaminoglikanları taklit 
edebilen peptit nanofiberler tasarlanmıştır. Büyüme faktörlerine bağlandığı ve 
damarlanmayı indüklediği bilinen glikozaminoglikan taklidi peptit nanofiberler 
tümleşik kardiyovasküler doku mühendisliği iskeleleri için umut verici yapılardır. Bu 
iv 
 
çalışmada, peptit nanofiberlerin hücre yapışmasını arttırdığı ve kardiyak miyoblast 
hücrelerinin kalp kası hücrelerine farklılaştığı gösterilmiştir. Bu farklılaşma gen 
ekspresyonu analizi ve immunoboyamalarla kanıtlanmıştır.  
Özet olarak, kas oluşumunu indükleyen, hücrelerarası iskelenin yapısal 
elemanlarından esinlenilerek tasarlanan, kendiliğinden toplanan peptit nanofiber 
platformlar hücrelerin farklılaşmasını desteklemişlerdir. Bu biyoaktif nanofiber 
sistemlerin kas doku mühendisliği uygulamalarında kullanılması umut 
vaadetmektedir.  
 
Anahtar Kelimeler: Peptit Nanofiberler, Hücrelerarası İskele, Biyomimetik, Basal 
Lamina, Çizgili Kas dokusu, Laminin, Fibronektin, Glikozaminoglikan, Kalp kası 
Rejenerasyonu.   
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1.1 Overview of Skeletal Muscle Tissue 
Skeletal muscle is a highly complex, hierarchically organized and heterogeneous 
tissue that is attached to, and allows the movement of, the various bones of the 
skeleton. It serves a multitude of functions, the most important of which is to 
generate longitudinal forces. This is established by the contraction of multiple 
myofibrils inside uniaxially directed bundles of myofibers 
1
, which are bundled 
together and attached to the skeleton by tendons.  
Skeletal muscle is composed of thousands of muscle fibers (myofibers) that are 
formed during development by the fusion of mononucleated myoblasts of 
mesodermal origin. Myofibers are multinucleated cellular syncytia and, since the 
generation of force requires substantial energy, must be supported constantly through 
an extensive network of blood vessels. As their constituent cells are terminally 
differentiated, mature muscle fibers are not capable of self-renewal. However, 
skeletal muscle is a dynamic tissue and can either increase or decrease its mass in 
response to a variety of environmental signals, such as starvation, exercise and 
nutrients 
2
. This self-renewal capacity is derived from a subpopulation of cells called 
satellite cells or myoblasts, which reside beneath the basal lamina. They constitute up 
to 1-5% of total skeletal muscle nuclei, depending on age and muscle fiber 
composition 
3
. These cells, first described in 1961, are found in healthy muscle 
fibers, remain in the mitotic quiescent state G0 and express CD 34, M-cadherin, PAX 
7, syndecan 3 and c-met 
4
. Satellite cells are unipotent adult stem cells and possess an 
exceptional self-renewal capacity. This ensures their persistence within the muscle 
while preserving the muscle’s ability to regenerate and repair after injury. These cells 
are activated in response to severe muscle damage, which triggers their asymetrical 
division and proliferation. Through asymmetrical division, some of these myocytes 
repopulate the stem cell niche, while others differentiate into myoblasts and rebuild 
the muscle by fusing with one another or with residual myofibers 
5
. As such, large 
numbers of new myotubes are formed only a few days after acute muscle damage, 
6
 
which serves as a testament to the remarkable regenerative capacity of skeletal 
muscle. This regeneration is regulated by locally produced growth factors that 
control cellular proliferation and differentiation 
7
. 
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Characteristics of the skeletal muscle fibers 
Skeletal muscle cells are postmitotic, multinucleated myotubes formed during the 
embryonic development by the fusion of myoblasts. The myotube matures into the 
long muscle cell, which possess diameter of 10 to 100 μm and lengths of up to 
several centimeters. Their total lengths can vary from several millimeters to more 
than 30 cm 
8
. 
Skeletal muscle fibers are characterized by their striated myofibrils, which are 
precisely organized contractile and regulatory proteins composed of repeating units 
arranged in series known as sarcomeres 
9
. Myofibrils are the smallest functional unit 
of a myofiber and a muscle fiber is composed of hundreds of myofibrils, which 
occupy about 80% of the sarcoplasm and are surrounded by mitochondria (also 
called sarcosomes). Myofibrils are principally composed of two major filaments 
formed by contractile proteins: thin filaments contain actin, while thick filaments 
incorporate myosin as well as many other cytoskeletal proteins 
10
. The capacity of 
the myofiber to produce force is directly related to the number of parallelly arranged 
sarcomeres within a muscle fibe 
 1.2 Skeletal Muscle Extracellular Matrix and Regeneration 
The extracellular matrix (ECM) is the non-cellular component present within all 
tissues and organs, and plays an important role not only in providing a structural 
framework for the cellular constituents but also by regulating cell behavior by 
initiating crucial biochemical and biomechanical cues that are required for tissue 
morphogenesis, differentiation and homeostasis 
11
. The ECM serves as a substrate for 
cell migration, modulates growth factor activity and transmits instructive and 
permissive signals from the microenvironment to cells to support their functional 
integrity 
12
. In muscle development, the primary role of the ECM is to function as a 
structural support for cell attachment, resulting in cell-to-extracellular matrix 
interactions that are required for cell migration. Depending on the tissue and 
development stage of the organism, ECM has a diverse nature and composition, 
containing several distinct families of molecules with disparate evolutionary origins. 
Although all ECMs are principally composed of water, proteins and polysaccharides, 
each tissue has an ECM with a unique composition and topology. ECM 
4 
 
glycoproteins include both collagens and a diverse array of non-collagenous proteins 
such as laminins, tenascins and fibronectin 
13
.  
Skeletal muscle is a hierarchically organized tissue and its ECM is ordered in several 
layers around whole muscle, mucle fascicles and muscle fibers. A layer of 
connective tissue, called the epimysium, surrounds each muscle, and bundles or 
fascicles of muscle cells are grouped together by perimysia, which are derived from 
the epimysial layer and contain the nerves and blood vessels that run through the 
muscle. Lastly, each muscle fiber is surrounded by a basal lamina and a mesh-like 
sheath of connective tissue called the endomysium. The basal lamina serves as a 
scaffold for muscle fiber formation and recovery from injury 
14
. Figure 1.1 
demonstrates the structure of skeletal muscle tissue and connective layers.  
1.2.1 Function and composition of the basal lamina 
The basement membrane that surrounds muscle fibers is closely associated with the 
sarcolemma, and provides a protective niche in which muscle regenerative cells 
(satellite cells) reside 
14
. It is a specialized ECM sheath composed of both an internal 
basal lamina and an external reticular lamina. The basement membrane is now 
known to be critical in muscle fiber structure and function. The actin cytoskeletons 
of muscle fibers are linked to their basal laminae, which support muscle function and 
protect against contraction-induced damage. Genetic studies of muscular dystrophy 
patients and animal models of muscular dystrophy have demonstrated the importance 
of the basement membrane in the maintenance of muscle integrity. In addition to the 
maintenance of muscle integrity, it is also essential in the promotion of myogenesis 
and muscle development. 
15
. 
The muscle ECM is formed by numerous components, including collagen, perlecan, 
laminin, entactin, fibronectin and several glycoproteins and proteoglycans. These 
proteins function as a scaffold that provides mechanical support for the cells and 
facilitates the formation of parallel myofibers by coordinating their attachment and 
alignment.  
Collagens are the most abundant proteins in the animal kingdom and, as a general 
feature, function to limit the distensibility of tissues, which are effectively 'kept in 
place' by the enormous tensile strengths of collagen fibrils 
16
. The muscle basement 
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membrane consists primarily of a type IV collagen network; however, types VI, XV, 
and XVIII are also present within the matrix 
17
. Fibronectin in particular is important 
for the maintenance of skeletal muscle, because it can bind to both the integrin 
receptors on cells and other molecules in the ECM.  
At the sarcolemma, laminins are bound by integrins and α-dystroglycan 18. Laminins 
are among the best studied of basement membrane components and can bind directly 
to type IV collagen, and may also be indirectly linked by fibronectin 
19
. Laminins are 
composed of three chains (α, β and γ) that exist in different combinations and form at 
least 16 different types of laminins. Laminins 211 and laminin 221 in the mature 
muscle bind to each other and to matrix proteins and serve to connect the muscle 
networks. Laminin-211 in the basement membrane is extremely important for the 
maintenance and stabilization of differentiated muscle 
20
. Interactions between 
matrix glycoproteins provide potential mechanisms for lateral force transmission 
from the myofiber 
21
. Together with the branched network structure of type IV 
collagen, these glycoproteins form the basis for basement membrane architecture.  
1.2.2 Course of Differentiation 
During embryonic development, skeletal muscle arises from mesodermal precursor 
cells 
22
. Adult skeletal muscles have a robust system of repair. It has been found that 
a large number of new myotubes arise within a couple days of acute muscle damage. 
Normally, satellite cells are quiescent and remain in the G0 phase of the cell cycle 
until they receive certain stimuli 
6
. Satellite cells express various proteins, including 
Pax7, CD34, c-met, Mcadherin, syndecan-3 and syndecan-4 
23-24
, that are important 
for their activation and proliferation in response to muscle damage. Several common 
stimuli that trigger the activation of satellite cells include exercise, injury from 
myotoxins, disease, denervation or other muscle damage. Following damage to the 
skeletal muscle, growth factors (GFs) and cytokines, such as hepatocyte growth 
factor, epidermal growth factor; platelet-derived growth factor BB; and members of 
the insulin-like growth factor (IGF) and fibroblast growth factor family 
25
 are 
released from the ECM 
26
, myofibers, endothelial cells, interstitial cells 
27
 and 
leukocytes 
28
. Interactions among these GFs and receptors on 
6 
 
 
Figure 1.1 Hierarchical organization of skeletal muscle tissue. Epimysium is the 
outermost layer that surrounds whole muscle tissue, perimysium is the connective 
tissue around fascicles and endomysium surrounds muscle fiber. Image acquired 
from wadeyoder.com.  
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quiescent satellite cells trigger satellite cell activation and result in their asymmetric 
proliferation. Activated satellite cells downregulate Pax7 expression and upregulate 
MyoD and Myf5 transcriptional activators, which direct these precursor cells to the 
myogenic linage 
29-30
. MyoD/Myf5 positive cells first become myoblasts and then 
stop proliferating and terminally differentiate into cells that begin expressing 
myogenin, myosin heavy chain (MHC), and muscle creatine kinase (MCK), which 
are muscle-specific genes. These myoblasts continue proliferating until they reach a 
sufficient number to begin fusing with existing fibers or with other myoblasts to form 
new multinucleated myotubes, which later on mature into muscle fibers 
31
. These 
sequential events are regulated through ECM components, growth factors and 
cytokines and occur within a dynamic microenvironment. Therefore, programming 
the environmental signals to induce the differentiation of progenitor cells for 
regenerative purposes is a challenging yet promising approach for functional 
restoration of damaged tissue.  As the focus of the present work is differentiation of 
skeletal muscle cells with bioactive scaffolds using advanced nanoscale systems, the 
next section will be devoted to an in-depth discussion of muscle injuries and tissue 
engineering strategies for the regeneration of muscle tissue.  
1.2 Muscle Injuries and Tissue Engineering Strategies for Repair 
Damage to skeletal muscle may occur throughout life due to exercise and 
contraction, abnormalities in the immune system, acute physical and chemical injury, 
or muscle degenerative diseases. Skeletal muscle injuries are a common cause of 
severe long-term pain and physical disability. Acute damage to skeletal muscle can 
occur by physical or chemical trauma. For example, excessively hot or cold 
temperatures and sharp or blunt traumas induce rapid myofiber necrosis. Likewise, 
ischemia/reperfusion also causes acute muscle damage. Also, during organ 
transplantation surgery, stroke and hypovolemic shock, or prolonged periods of zero 
blood flow induce muscle dysfunction through the loss of cellular energy supplies 
and results in the accumulation of potentially toxic tissue metabolites. Restoration of 
blood flow is essential for the rescue of ischemic muscle. Therefore, there is a strong 
need to improve the short- and long-term management of skeletal muscle injuries. 
According to the principle of conservative management, muscle injuries heal 
conservatively. It follows the RICE protocol (rest, ice, compression, and elevation). 
Other therapies also exist, including the local application of heat and passive motion 
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exercises or drug therapy, which typically consists of nonsteroidal anti-inflammatory 
drugs (NSAIDs) and intramuscular corticosteroids 
32
. However, current treatment 
methods do not seem to obtain complete restoration of normal functionality, and new 
biological therapies could represent new and more effective strategies for the 
restoration of muscle tissue. Current biological strategies for the management of 
muscle injuries are growth factor therapy 
33-36
, cell therapy 
37
, platelet-rich plasma 
(PRP) therapy 
38-39
 and tissue engineering scaffolds.   
In skeletal muscle injuries, tissue engineering represents a biological alternative for 
the replacement of large tissue loss after severe damage. Tissue engineering could 
allow skeletal muscle fibers to be grown in culture and then transplanted into a 
patient to improve their physical and psychological symptoms. A comprehensive 
understanding of tissue structure and the ability to imitate its molecular composition 
are important to effectively grow tissues for therapeutic use. Biomaterials that 
emulate the natural tissue structure can be designed and used as controlled 
microenvironments for regeneration and tissue development.  
Efficient skeletal muscle regeneration is strongly correlated with the properties of the 
biomaterials used for scaffold generation and with the regenerative potential of the 
cells used for scaffold seeding. Biomaterials with different physiochemical features 
and compositions, as well as different biological characteristics, have been used to 
fabricate efficient tissue engineering scaffolds. Both natural and synthetic materials 
are used to mimic the structural and biomechanical properties of the native tissue. 
Materials commonly used as scaffolds are hydrogels, polymer scaffolds (PLA, PLLA, 
PDMS) 
40-42
 and natural products such as collagen 
43
, fibrin 
44-45
 hyaluronan 
41
, 
chitosan 
46
 and matrigel. Kroehne et al. have used collagen scaffolds with parallel 
oriented pores to reproduce the three-dimensional organization of skeletal muscle 
and showed that this scaffold has the ability to induce skeletal muscle-like tissue 
regeneration 
43
. In addition, Ma et al. reported the ability of 3-D collagen scaffolds 
seeded with myoblasts to improve muscle healing with an increased quantity of 
innervated and vascularized regenerated muscle fibers 
47
. Fibrin is another natural 
material used as a scaffold and Page et al. demonstrated that fibrin microthread 
scaffolds provide an efficient delivery system for cell-based therapies and improve 
the regeneration of a large defect in the tibialis anterior of the mouse 
48
. 
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Another approach is the use of decellularized tissues as scaffolds, which readily 
provide the native extracellular microenvironment experienced by cells. Borschel et 
al. used acellular muscles with injected myoblasts and showed the production of 
longitudinal contractile force upon electrical stimulation after differentiation 
49
. In 
another study, Sicari et al. implanted porcine urinary bladder ECM scaffold to mice 
and demonstrated new skeletal muscle formation. Moreover, in a parallel human 
clinical study, scaffold-treated patients with volumetric muscle loss showed similar 
outcomes with mice and improved limb strength during physical therapy 
50
. 
In addition to its composition, the structural features of biomaterial are important for 
the alignment of cells, since skeletal muscle tissue is ordered into aligned bundles 
and tissue constructs should be aligned to function after engraftment. Therefore, 
biodegradable materials with parallel oriented pores and aligned or grooved 
morphologies have been used to reproduce the three-dimensional organization of 
skeletal muscle. Ricotti et al. fabricated electrospun nanofibrous PHB scaffolds and 
demonstrated that the aligned nanofibrous mesh decreases the proliferation activity 
and provides a higher differentiative stimulus 
51
. In another study, grooved 
polystyrene substrates were conjugated with RGD and were shown to enhance 
adhesion, growth and differentiation of C2C12 cells 
52
.  
1.4 Heart And Cardiac Muscle Tissue   
Heart is an organ that operates as an engine for the circulatory system. It 
accomplishes this task with a tissue structure that is specially adapted to meet the 
demands of constant activity during times of rest and exercise. It has three layers; 
epicardium, myocardium and endocardium, where myocardium is the muscular 
middle layer of the heart wall. Myocardium is composed of cardiac muscle fibers, 
which occupy most of the tissue volume but constitute only 30% of the total number 
of cells in a normal adult heart. Remaining cell populations are non-cardiomyocyte 
cell types, among which cardiac fibroblasts represent the vast majority 
53
.  
Heart contraction is an autonomic function of the peripheral nervous system, and the 
myocardium stimulates contractions and relaxations to pump blood from the 
ventricles and to allow the atria to receive blood, respectively.  
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Cardiac muscle is involuntary, so functionally, it is smilar to smooth muscle. 
However, anatomically cardiac muscle more closely resembles skeletal muscle due 
to being striated as a result of the parallel arrangement of actin and myosin filaments. 
Cardiac muscle fibres are long, cylindrical cells with one or sometimes two nuclei 
which are centrally located within the cell. Also, the cardiac muscle has several 
unique features such as intercalated discs, which are connections between two 
adjacent cardiac cells and help muscle cells to contract rapidly as a single unit. 
Intercalated discs are irregular transverse thickenings of the sarcolemma that contain 
desmosomes and gap junctions and ensure proper functioning of the cardiac muscle 
as an effective pump 
54-55
. 
1.4.1 Myocardial extracellular matrix 
There is a connective tissue layer between the muscle fibers, analogous to the 
endomysium of skeletal muscle, and it supports capillary network necessary to meet 
the high metabolic demand of strong continuous activity. The ECM not only 
facilitates the exchange of mechanical, electrical and chemical signals during 
homeostasis, but also plays essential roles in development, remodeling and signaling 
in the cardiovascular system 
56
. This three-dimensional structure acts as a framework 
for myocytes, fibroblasts and endothelial cells contained in the myocardium and the 
vasculature to align and build a network. ECM components are also important in 
determining the mechanics of myocardium, pericardium, blood vessels and valves 
57
. 
The extracellular space can be divided into solid and fluid components, of which 
organization, composition and density are dynamic both in normal and pathological 
conditions. The fluid components of the matrix contribute to the distribution of 
soluble factors and other molecules related to different processes. Also, these 
components act as binding sites for soluble factors and effect their distribution and 
availability. Other components play roles in accumulating water due to their 
hydrophilic nature and therefore providing resistance to compression. The 
extracellular space and its components also serve to connect the cellular components 
of the myocardium, effectively linking each individual cell and coordinating the 
contraction of the whole tissue. In addition, cellular and acellular signals and ECM 
components involved in cell-ECM interactions during post-myocardial infarction 
(MI) or hypertensive remodeling may contribute to the progression toward recovery 
or heart failure by playing agonistic or antagonistic roles 
56
.  
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The ECM is a collection of macromolecular proteoglycans, glycoproteins, proteases, 
collagens, growth factors and cytokines. Fibroblasts and vascular smooth muscle 
cells (VSMC) primarily contribute to the secretion of fibronectin and collagens type I 
and III, while VSMCs, myocytes and endothelial cells produce type IV collagen and 
laminins 
58
.  
Proteoglycans have recently begun to receive increased attention for their potential 
signalling roles. During the synthesis of proteoglycans; glycosaminoglycans, which 
are polysaccharide chains consisting of repeating amino sugar and uronic acid 
disaccharide units, are covalently linked to the core protein, sulphated and then 
secreted into the microenvironment. Glycosaminoglycans (GAGs), and especially 
sulphated GAGs, have a strongly negative charge, which attracts water and results in 
large hydrodynamic volumes. When the muscle is placed under pressure, the water is 
removed and GAGs return to their original volume, which allows proteoglycans to 
act as a lubricant and makes them essential in tissues undergoing continuous cycles 
of pressure-relief, such as cartilage or cardiac muscle 
59
. Furthermore, 
glycosaminoglycans also play major roles in cell signalling, angiogenesis 
60
, axonal 
growth 
61
, tumor progression 
62
, and anti-coagulation 
63
. 
Heparan sulphate is a common glycosaminoglycan and can bind to multiple growth 
factors and cytokines through polysaccharide chains. These factors include vascular 
endothelial growth factor (VEGF), BMPs, and fibroblast growth factors (FGFs), and 
TGF-βs, which have been demonstrated to be important for cardiac development 64. 
Numerous studies have revealed that ECM composition differs during different 
physiological states and differences in the microenvironment are largely driven by 
cell-cell and cell-matrix interactions within the developing and adult heart. 
Alterations in the signaling pathways that regulate the production of ECM 
components, or perturbations in their expression patterns, can lead to congenital heart 
diseases and cardiac malfunctions 
64
. 
1.5 Cardiovascular Diseases and Cardiac Regeneration  
One of the leading causes of death worldwide, ischemic heart disease is characterized 
by reduced blood supply to the heart muscle, which leads to a deficit in the 
production of the energy required for cardiac contraction. It is a multi-factorial 
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condition, resulting from a combination of genetics, life style and environment 
factors. Risk factors for ischaemic heart disease include family history, LDL 
cholesterol, high blood pressure and obesity.  
Acute myocardial infarction (AMI) is a subcategory of ischaemic heart disease and 
occurs when the blood supply is completely cut at the level of a coronary artery 
65
, 
leading to a permanent tissue ischemia. While death does not always occur, the 
disease nonetheless results in the large-scale loss of cardiac muscle, diminishes the 
contraction capability of the heart 
66
 and frequently causes heart failure.  
Current therapies for AMI include medical treatment, heart transplantation and 
implantation of mechanical ventricular assist devices. With the exception of 
transplantation and mechanical assistance devices, current pharmacological, 
interventional or operative therapies for the disease suffer from an inability to 
compensate the decreased pumping capacity of heart following the irreversible loss 
of functional cardiomyocytes 
67
. Thus, new solutions are required to regenerate the 
damaged myocardium, to overcome the bad prognosis of patients with heart failure, 
and to address the shortage of heart donors.  
Cellular repair strategies for heart disease include direct transplantation of cells into 
the damaged tissue, tissue engineering techniques for the ex vivo development of 
replacement tissue and therapies that prompt the heart to regenerate damaged tissues. 
Cell Therapy 
The basis of cell therapy is the repopulation of injured myocardium by 
transplantation of healthy cells. Although heart was once thought to be a terminally 
differentiated organ and therefore incapable of replenishing lost myocytes, Beltrami 
et al. have demonstrated that mammalian cardiac myocytes retain some capacity for 
division 
68
 and identified endogenous cardiac progenitor cells, which retain some 
potential for differentiation into endothelial cells, smooth muscle cells and cardiac 
myocytes 
69
. Following the discovery that native progenitor cells exist in the adult 
heart, the delivery of these progenitor cells have been studied as a method to 
facilitate the generation of a functional myocardium, and this has eventually been 
translated into the clinic as a cell-based therapy to treat heart disease 
70
. However, a 
key concern for stem cell transplantation is the selection of cell source, which 
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determines the safety and efficacy after engraftment. In addition, clinical trials with 
bone marrow progenitors have shown modest improvements in ventricular function 
70-72
.  
Various cell types have been considered as candidates for therapeutic delivery in 
humans, including BMCs, myocardium or adipose tissue derived cells (which were 
already used in clinical trials), endothelial progenitors, hematopoietic stem cells and 
pluripotent stem cells 
65,67
.  
Currently, bone marrow is the most frequent source of cells used for cell therapy. 
Jackson et al. have reported that the transplantation of bone marrow with labelled 
haematopoietic stem cells followed by myocardial infarction results in a low rate of 
cardiomyocyte differentiation from the transplanted cells 
73
. However, many other 
studies in animals could not demonstrate cardiomyocyte differentiation from 
haematopoietic progenitor cells, 
74-75
 nor did they find any improvement in cardiac 
function following haematopoietic stem cell transplantation 
76
. On the other hand, 
bone marrow-derived cells have been used in small clinical trials with apparent 
success, 
77-79
 yet most studies demonstrated modest cell therapy-mediated 
improvements in ventricular function 
80
.  
Another source for cell therapy is endogenous cardiac progenitor cells, since the 
initial discovery had demonstrated that there existed an endogenous population of 
progenitor cells resident in the mammalian heart. The advantage of this approach is 
the feasibility of autologous transfer, although the ex vivo expansion of these cells is 
necessary. However, a principal problem with cardiac progenitors is the lack of 
definitive markers 
65
. Small populations of stem cells in the mammalian myocardium 
express the cell-surface markers Kit12 or Sca1 
81
. Animal studies reported that these 
cells differentiated into cardiomyocytes, smooth muscle cells and vascular 
endothelium, replacing the majority of the infarcted tissue and improving ventricular 
function significantly when engrafted to heart 
82-83
.  
1.6 Cardiovascular Tissue Engineering Strategies  
As an extension of cell transplantation, tissue engineering with biocompatible 
scaffolds can provide an appropriate structural and three-dimensional 
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microenvironment to integrate myocytes with the host tissue and develop the 
vasculature necessary to support blood flow.  
Design of the biomaterial scaffold is important to mimic the native cardiac tissue in 
terms of mechanical properties, structure of the underlying matrix, and presence of 
vasculature. As such, tissue engineering constructs should be mechanically robust yet 
flexible, electrophysiologically stable, vascularized or capable of vascularization 
after implantation, non-immunogenic and contractile 
84
. 
Recent studies have explored the possibility of using decellularized hearts as 
scaffolds; however, although decellularized scaffolds are suitable for replacing native 
tissue with a new tissue layer of the same thickness, injectible hydrogels are less 
invasive in acute MI 
85
.  
A common approach is to seed cardiomyocytes onto porous scaffolds, typically from 
a biodegradable polymer such as poly(lactic-coglycolicacid) or natural polymers 
such as collagen and fibrin 
86
. Zimmermann et al. developed collagen gels into which 
cardiomyocytes are embedded and mechanically conditioned in a cyclic stretching 
device, and studies with this gel suggest that some of the cardiomyocytes survive 
after transplantation into uninjured hearts and undergo further proliferation 
87
.  
Similarly, Zhang et al. used fibrin gels and compared the maturation of human 
embryonic stem cell-derived cardiomyocytes in 2D monolayers and 3D patch 
cultures. As a result, they observed that cells in 3D fibrin-based patches exhibited 
longer sarcomeres and increased expression of genes associated with contractile 
function 
86
. 
Another study has shown that porous alginate scaffolds with seeded cardiomyocytes 
yield 3D high-density cardiac constructs and optimized the cell seeding requirements 
for a uniform distribution in a 3-dimensional structure 
88
.   
The ability to support vascularization is one of the most important requirements for 
biomaterial or tissue engineering constructs to correctly facilitate the regeneration of 
damaged myocardial tissue 
89
. 3D cell constructs generally lack the vascular network 
that exists in normal tissues. However, a bioengineered myocardial tissue graft 
requires persistent neovascularization, or angiogenesis, for its growth and survival 
after implantation. This factor is essential because cardiomyocytes are very sensitive 
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to prolonged ischemia and may die by necrosis and apoptosis if deprived of oxygen, 
and the engineered heart muscle should survive the ischemic period to maintain 
viability and function 
84
. Strategies to promote vessel formation include cell tri-
culture, use of growth factors and peptides and the engineering of novel 
proangiogenic scaffolds 
90
. 
Xiang et al. reported succesful neovascularization in the infarct area following 
implantation of collagen-GAG scaffolds in combination with bone marrow-derived 
mesenchymal stem cells 
91
. 
Leor et al. also used porous sodium alginate scaffolds to grow fetal rat cardiac cells 
within a 3D biograft, and transplanted this scaffold into cardiac tissue. Intensive 
neovascularization from the neighbouring coronary network was observed through 
histological analysis 
92
. In another study, Chiu et al. developed angiogenic and 
cardioprotective peptide-encapsulated collagen–chitosan hydrogels and observed 
increased formation of mature blood vessels after the injection of the hydrogel into 
rat myocardium. The increase in mature blood vessel numbers in turn enhanced the 
presence of cardiomyocytes while reducing tissue loss 3 weeks post-MI 
93
.  
Another approach for cardiac tissue regeneration is the site-specific delivery of 
angiogenic growth factors from tissue-engineered devices to stimulate localized 
vessel recruitment to the cell transplant and wound area. For example, Perets et al. 
constructed a porous alginate scaffold that incorporates tiny poly (lactic-co-glycolic 
acid) microspheres capable of controlling the release of angiogenic factors such as 
bFGF, which was released from the scaffolds in a controlled manner in vitro and  
accelerated the vascularization of the mesenteric membrane in the rat peritoneum 
94
. 
Figure 1.2 demonstrates the current myocardial tissue engineering strategies. 
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Figure 1.2 Scheme of the present major strategies for cardiac tissue engineering 
using (a) collagen strings, (b) biodegradable gels or (c) cardiac cell sheets (Adapted 
with permission from Zammaretti et al. Current Opinion in Biotechnology 2004, 
15:430–434.) 
 
 
 
 
 
 
Angiogenesis can also be promoted under certain structure geometries. Madden et al. 
created methacrylate-based hydrogel scaffolds consisting of interconnected pores, 
which were 30–40 mm in diameter, by microtemplating and showed that this system 
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supports the growth of hESC-derived cardiomyocytes in vitro and is proangiogenic, 
promotive of vessel infiltration and able to reduce scarring in vivo 
95
. 
Another approach to increase vacularization is biomimetics, which encompasses the 
design of scaffolds that physically and chemically resemble growth factors or the 
ECM of heart tissue. Narmoneva et al. cocultured endothelial cells (EC) and neonatal 
cardiac myocytes (CM) in 3-D RADA-peptide hydrogels and demonstrated that, 
when these cells are cultured together, interactions between the cells promote 
myocyte reorganization and the endothelial cells form capillary-like networks, which 
in turn promote spontaneous contractions 
96
.  
Webber et al. designed peptide amphiphile-based supramolecular nanostructures 
which mimic the activity of VEGF and facilitate increased tissue perfusion and 
functional recovery in ischemic tissue 
97
. Mammadov et al. also used peptide 
amphiphiles to mimic heparan sulphate and showed that glycosaminoglycan mimetic 
nanofibers bind to the growth factors secreted by cells and enhance angiogenesis 
without the addition of exogenous growth factors 
98
. 
In this thesis, we synthesized heparin sulphate-mimetic peptide nanofibers, which 
were previously shown to induce angiogenesis 
98
, and examined their effect on the 
induction of cardiomyocyte differentiation in vitro. This study is combined with an in 
vivo myocardial infarction model and an analysis of peptide-mediated 
revascularization in the infracted area. We therefore assessed the regenerative 
potential of an ECM-mimetic peptide amphiphile scaffold to heal the myocardium 
after infarction.  
1.7 Motivation and Goals   
Peptide amphiphiles allow incorporation of various functional biological signals 
into their primary sequence and form higher order nanostructures that display 
complex architectures and biochemical characteristics similar to those of native 
tissue microenvironments under physiological conditions. These properties make 
them ideal candidates as bioactive scaffolds for regenerative medicine and tissue 
engineering applications. Peptide sequences derived from the active sites of the 
ECM components, which have important roles in muscle regeneration and 
development, were incorporated into peptide amphiphile nanofibers to create a 
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microenvironment that can both physically support cellular growth and supply the 
bioactive signals required for the induction of differentiation. In the first chapter, 
I discussed the effect of biomimetic peptide amphiphiles designed to mimic the 
basal lamina of skeletal muscle on the differentiation of myoblast cells. In the 
second chapter, I focused on angiogenic peptide amphiphiles and their effect on 
cardiomyocyte differentiation.  
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CHAPTER 2. 
 BASAL LAMINA MIMETIC PEPTIDE NANOFIBERS FOR SKELETAL 
MUSCLE DIFFERENTIATION 
Part of this study was submitted to be published as “Basal Lamina Mimetic 
Nanofibrous Peptide Networks for Skeletal Myogenesis”, Immihan Ceren Garip, 
Nuray Gunduz, Murat Kilinc, Mustafa O. Guler and Ayse B. Tekinay. 
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2.1 INTRODUCTION 
Skeletal muscle tissue constitutes 40% of the total body weight and is crucial for 
physical locomotion. Traumatic injury, tumor excision, congenital defects or 
myopathies compromise muscle function and mobility and necessitate muscle tissue 
reconstruction 
99
. Muscle stem cell transplantation is a promising treatment against 
skeletal muscle trauma; however, isolated stem cells drastically lose their ability to 
form myotubes and function adequately after in vitro expansion. Therefore, 
antagonism between differentiation and proliferation hampers the therapy 
100
. On the 
other hand, transplantation of non-cultured muscle stem cells to damaged muscle 
tissue immediately after isolation is quite effective in new myotube formation; 
however, it is required to harvest approximately 3-4 kg of muscle tissue to regenerate 
1 x 10
5
 mm
3
 of muscle 
101-102
. As such, due to lack of donor tissue availability, 
autologous graft surgery is limited. Another one of the most important issues in 
muscle disorders is the infiltration of connective tissue to the site of injury. Presence 
of connective tissue inside the muscle which does not possess any contractile 
capability leaves non functional scar even after healing. Such scars lead to severe 
weakness in muscles and increase the possibility of fat accumulation within muscle 
throughout aging. Proper treatment to muscle injuries such as tears or traumas 
requires use of sophisticated materials to prevent infiltration of connective tissue. To 
this end, regenerative medicine is a promising alternative solution for the treatment 
of myopathies as well as regeneration of age-related muscle wasting in elderly 
people. It is still challenging to engineer skeletal muscle, yet numerous techniques 
are being developed 
51,103-105
. One of the strategies is fabrication of aligned scaffolds 
for engineering muscle tissue. Aviss et al. fabricated align polymer fibers with 
PLGA and demonstrated differentiated long myotubes by immunostainings 
104
. 
Similarly, myotube assembly was shown on nanofibrous and micropatterned 
polymers by Huang et al. They concluded that microgrooves cause the alignment of 
myoblasts and cytoskeletal proteins and promote myotube assembly along the 
nanofibers 
106
.   
Biomimicry to generate favorable microenvironment for induction of differentiation 
is another promising strategy. ECM mimetic scaffolds for differentiation and tissue 
regeneration are under investigation for many tissues including bone, cartilage, 
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myocardium and nerve. For skeletal muscle, basal lamina could be target of 
biomimetic strategies. Basal lamina is a type of ECM that surrounds muscle fibers 
and takes role in fiber force transmission, repair and maintenance. Fibrous 
architecture and biochemical components of basal lamina support development and 
function of skeletal muscle. Thus, scaffolds mimicking basal lamina are promising 
candidates for efficient muscle tissue regeneration 
107
. Since nano- to micrometric 
topography is known to greatly influence cellular behavior including differentiation 
108
, micro and nanofabrication techniques are currently used to develop skeletal 
muscle constructs, with specific focus on topographical features to induce alignment 
of myotubes 
42,109-110
. Similarly, ECM proteins such as collagen, fibronectin and 
laminin or their cell adhesion domains are used to coat the engineered surfaces for 
triggering cell growth and differentiation 
111-112
. Previously, it has been shown that 
laminin has an important role in myogenic differentiation by stimulating proliferation 
and motility of cells and leading them to bipolar shape of fused cells 
113
. The YIGSR 
and IKVAV peptide sequences derived from β1 and α1 cell binding domains of 
laminin, respectively, have been utilized to imitate the natural microenvironment in 
tissue engineering strategies. The RGD peptide is another important cell adhesion 
epitope found in many proteins including fibronectin
114
 and was also shown to 
promote migration and fusion of cells in an in vitro myogenesis model system. 
Peptide amphiphiles enable incorporation of various functional biological signals 
into their primary sequence and give rise to formation of higher order nanostructures 
that display complex architecture and biochemical characteristics of native tissue 
microenvironment under physiological conditions. Owing to their inherent 
biocompatibility and tailorable properties, variety of studies demonstrated peptide 
amphiphiles as versatile tools for the design of artificial ECM-like scaffolds 
115
. 
Various shapes including high-aspect ratio nanofibers and nano-networks can be 
generated through programmed self-assembly driven by multiple types of non-
covalent interactions. These properties make them ideal candidates as bioactive 
scaffolds for regenerative medicine and tissue engineering applications. 
This chapter presents utilization of laminin-mimetic and fibronectin-mimetic self-
assembled peptide nanofibers for myogenic induction of progenitor cells. These 
peptide amphiphiles resemble the structure of basement membrane skeletal muscle 
cells. I describe below the design and characterization of peptide nanofibers and the 
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affect of these nanofibers on myogenic cell behaviors such as viability, proliferation 
and differentiation. 
2.2 EXPERIMENTAL 
2.2.1 Chemicals and Solutions 
9-Fluorenylmethoxycarbonyl (Fmoc) and tert-butoxycarbonyl (Boc) protected 
amino acids, [4-[α-(2’,4’-dimethoxyphenyl)Fmoc-aminomethyl]phenoxy] 
acetamidonorleucyl-MBHA resin (Rink amide MBHA resin), 2-(1H-
Benzotriazol-1-yl)-1,1,3,3 tetramethyluronium hexafluorophosphate (HBTU) and  
Lauric acid were purchased from NovaBiochem, ABCR and Merck. Piperidine, 
Acetic anhydride, Dichloromethane (DCM) and Dimethylformamide (DMF), N, 
N-diisopropylethylamine (DIEA), trifluoroacetic acid (TFA) : triisoproplysilane 
(TIS) were purchased form Sigma. 
Cell Culture Reagents: 
Dulbecco’s Modified Eagle Medium (DMEM), Penicillin/streptomycin (PS) 
antibiotic combination and fetal bovine serum (FBS) were purchased from 
Invitrogen Gibco.  
2.2.2 Synthesis of Peptide Amphiphiles 
Peptide amphiphile molecules were synthesized using solid phase peptide 
synthesis method with Rink amide MBHA resin and aspartic acid loaded and 
glutamic acid loaded Wang resin. FN-PA (Lauryl-VVAGERGD-OH) and E-PA 
(Lauryl-VVAGE-OH) were synthesized on Fmoc-Asp-Wang and Fmoc-Glu-
Wang resins, respectively. LM-PA (Lauryl-VVAGKKIKVAV-Am) and K-PA 
(Lauryl-VVAGK-Am) were synthesized on Rink amide resins. For coupling of 
amino acids, 1.95 molar equivalents of HBTU and 3 equivalents of DIEA for 1 
equivalent of starting resin were used with 2 equivalents of amino acid in 10 mL 
of dimethylformamide (DMF). Each amino acid coupling took 2 h and removal of 
Fmoc protecting group was performed with 20% piperidine/dimethylformamide 
(DMF) solution for 20 min. Lauric acid addition was performed similarly to 
amino acid coupling except that coupling time was 4 h. In order to acetylate the 
unreacted amine groups after each coupling step, 10% acetic anhydride–DMF 
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solution was used after each coupling. Dichloromethane (DCM) and DMF were 
used for washing steps. Peptide cleavage from the resin and deprotection were 
carried out with 95% cleavage cocktail (95:2.5:2.5 trifluoroacetic acid (TFA): 
triisopropylsilane (TIS): water) for 2 h at room temperature. Excess TFA was 
removed by rotary evaporation. Ice-cold diethyl ether was used to precipitate the 
remaining PA solution overnight at -20 °C. Centrifugation was used to collect the 
precipitate and ultrapure water was used to dissolve the PA precipitate. Solution 
was frozen at −80 °C and then lyophilized for 3 days.  
To characterize synthesized peptide amphiphiles, a quadruple time of ﬂight (Q-TOF) 
mass spectrometer with electrospray ionization (ESI) source equipped with a reverse-
phase analytical high performance liquid chromatography (HPLC) was used. Agilent 
Zorbax Extend-C18 2.1 x 50 mm column was used for negatively charged peptide 
molecules and Zorbax SB-C8 4.6 x 100 mm column was used for positively charged 
peptide molecules respectively. A gradient of water (0.1% formic acid and 0.1% 
NH4OH) and acetonitrile (0.1% formic acid and 0.1% NH4OH) were used for liquid 
chromatography. In order to purify synthesized peptide amphiphiles, reverse-phase 
preparative HPLC equipped with Zorbax Extend-C18 21.2 x 150 mm column for 
negatively charged peptide molecules and Zorbax SB-C8 21.2 x 150 mm column for 
positively charged peptide molecules was used. A gradient of water (0.1% 
Acetonitrile and 0.1% NH4OH) and acetonitrile (0.1% formic acid and 0.1% 
NH4OH) were used. Furthermore, positively-charged peptide amphiphiles were 
treated with 0.1 M HCl solution in order to remove residual TFA at the end. 
Table 2.1 Mass and molecular weights of synthesized peptide amphiphiles 
Name Sequence Exact Mass Molecular Weight  
LM-PA Lauryl-VVAGKKIKVAV-NH2 1291.93 1292.74 
FN-PA Lauryl-VVAGERGD 983.57 984.15 
E-PA Lauryl-VVAGE 655.42 655.82 
K-PA Lauryl-VVAGK- NH2 653.48 653.90 
 
2.2.3 Preparation of Peptide Nanofiber Gels  
Solutions were prepared by dissolving PAs in sterile double distilled water and 
their pH values were adjusted to 7.4. Each PA molecule was separately heated at 
24 
 
70 °C for 5 min and then mixed at a different volume ratio to have final neutral 
charge. Following 30 s sonication, mixture of PA combinations were reheated at 
70 °C for another 5 min. Plates and coverslips were then coated with PA 
mixtures. With the annealing procedure, homogenous coating over the surface 
was achieved. After 30 min of incubation at 37 °C, coatings were left to dry 
overnight under sterile conditions. 
2.2.4 Characterizations of Self-Assembled Peptide Nanostructures 
Chemical and mechanical characterizations of peptide amphiphiles were 
performed using CD, SEM, TEM, and rheology.  
2.2.4.1 Secondary Structure Analaysis by Circular Dichroism:  
LM-PA, FN-PA and E-PA were mixed at 2 x 10
-4
 M concentration. Peptides were 
heated for 5 min, mixed, sonicated and heated again for 5 min before 
measurement. Following cooling of mixtures at room temperature, scanning was 
done between 190 nm to 300 nm using a digital integration time of 1 s, a band 
width of 1 nm and with standard sensitivity. Secondary structures of individual 
PA molecules were also analyzed by using 2 x 10
-4
 M concentration. Molar 
elipticity was calculated with the data obtained from measurements 
2.2.4.1 Scanning Electron Microscopy:  
SEM samples were prepared by mixing 1% (wt/V) LM-PA and FN-PA at 2:3 
ratio and LM-PA and E-PA at 2:3 ratios to have neutral charge. All the samples 
were prepared with same annealing procedure. Before serial ethanol dehydration 
step, gels were put onto silicon wafers and incubated for 20 min cooling and 
stabilization. Then serial ethanol dehydration step was performed. After gradual 
ethanol dehydration, gels were dried in a critical point dryer (Tousimis, 
Autosamdri-815B, Series C critical point dryer) and coated with 5 nm Au/Pd 
before imaging. PA gels were then observed with scanning electron microscopy 
(SEM, FEI Quanta 200 FEG) at 10 kV. 
2.2.4.3 Transmission Electron Microscopy: 
For analysis samples were prepared with same annealing procedure, 1 mM E-PA 
and 1 mM FN-PA were mixed with 1 mM LM-PA in 3:2 volumes and after 
heating and cooling, mixtures were put on a 200-mesh carbon TEM grid for 5 min 
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followed by 2 wt% uranyl acetate staining for 40 s. Further, sample was left at 
flow hood to dry until a dried film was obtained. For E/K-PA 0.5 mM E-PA was 
mixed with 1 mM K-PA. TEM and STEM images were acquired at 300 kV. 
2.2.4.4 Mechanical Characterization by Rheology:  
Total volume of 300 μL of 1% (wt/V) PAs was used to analyze mechanical 
properties of gels. After heating, individual PAs were mixed on the center of the 
plate, whose temperature was set to 70 °C, and incubated for 5 min. Oscillatory 
Rheology (Anton Paar Physica RM301 rheometer) operating with a 25 mm 
parallel plate configuration was used for measurement, after 15 min of cooling, 
with 0.5 mm gap distance, 100 - 0.1 rad/s angular frequency and 0.5% shear 
strain. 
2.2.5 Cell Culture 
2.2.5.1 Cell Adhesion and Viability 
Viability of Cells 
Cytotoxicity of samples was evaluated using Live-Dead Assay (Invitrogen). 
C2C12 cells were seeded in DMEM supplemented with 10% FBS and %1 
Penn/Strep under conditions of 5% CO2 at 37 ⁰C.  
Well plates were coated with LM/E-PA, LM/FN-PA and E/K-PA. Coating was 
done as mentioned in the nanofiber formation section. Before coating process, 
solutions were sterilized under UV for at least 1 h.  Gel formation was achieved 
at 37 °C for 30 min and drying was performed under laminar flow hood 
overnight. Before experiments, dried plates were further sterilized under UV light 
for 1 h and washed with medium to remove unbound nanofibers. C2C12 cells 
were cultured in 96-well plate in 200 μL medium per well with seeding density of 
5 x 10
3
 cells/well for 24 h. After 24 h of standard incubation, plate was 
centrifuged for 5 min at 2500 rpm to keep dead cells on the surface. Then wells 
were washed with 1x PBS and 2 min centrifugation was done in each step. 
Calcein AM and Ethidium Homodimer reagents were diluted in PBS so that they 
had 2 µM and 4 µM concentration, respectively. After subsequent 40 min 
incubation at dark, cells were observed under fluorescent microscope. Experiment 
was carried out with n=4 and, images were taken from 5 different locations per 
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well. Live and dead cells were counted with ImageJ (NIH) software. Viability 
was assessed by calculating ratio of live cells over total cell number. 
Cell Adhesion: 
C2C12 cells were incubated for 1 h in serum free DMEM medium supplemented 
with 4 mg/mL Bovine Serum Albumin (BSA) and 50 mg/mL cyclohexamide at 
standard culture conditions in 75-cm tissue culture flask before seeding. After 1 h, 
cells were removed from tissue culture plate by trypsinization and seeded onto the 
coated 96-well plates at a density of 3 x 10
3
 cells/well. After 2 h incubation in serum-
free medium at standard culture conditions, Calcein AM (Invitrogen) staining (2 μM) 
for 40 min was performed. Cell adhesion was quantified directly by counting the 
number of cells using Image J program from the images taken with fluorescent 
microscope. Images were taken from 5 different random locations per well, and 
experiment was carried out with n=4. Results were then normalized to tissue culture 
plate counts. 
2.2.5.2 Cell Proliferation 
Proliferation of cells on LM/E-PA and LM/FN-PA coatings was assessed using BrdU 
assay (Roche). Cells were seeded onto PA coated 96-well plate and uncoated tissue 
culture plates (TCP) at a density of 3 x 10
3
 cells/well. Cells were incubated in 
standard cell culture medium supplemented with 100 µM BrdU labeling solution for 
48 h. At the end of the incubation, BrdU incorporation assay was performed.  Cells 
were fixed with FixDenat solution for 30 min and anti BrdU-POD solution was 
added into wells. Following 90 min incubation and tapping, substrate solution was 
added into wells and proliferation rates of the cells were quantified by measuring the 
absorbance (370 nm, with 492 nm reference wavelength) with microplate reader. 
2.2.6 Cell Differentiation 
Cells were seeded at a density of 5000 and 15000 onto 96-well plate and 24 well 
plates respectively. Before differentiation induction, they were cultured in 10% FBS 
and %1 Penn/Strep under conditions of 5% CO2 at 37 ⁰C for 2 days to let them reach 
confluence. Afterwards, their culture medium was replaced with DMEM: Ham’s F10 
Nutrient mix supplemented with 2% FBS, 1% penicillin/streptomycin and 10 µg/mL 
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insulin. In all experiments, media were changed every day. Cells were used at 
passage numbers between 8-10. 
2.2.6.1 Morphology  
During differentiation period, cells on 96-well plate were controlled every day under 
inverted microscope. Images were taken from 4 different random locations per well, 
and experiment was carried out with n=3. Number, length and diameter of 
differentiated myotubes were count by using Image J, and its cell counter plugin. 
Scale bar in the figures were used to set the measurement length from μm to pixel 
and length measurement tool of the program was used to analyze the myotube 
lengths and diameters. 
2.2.6.2 Myogenin and Myosin Heavy Chain Gene Expression  
Quantitative RT-PCR was used for gene expression analyses. Total RNA was 
isolated from C2C12 samples using TRIzol (Invitrogen) reagent. Nanodrop 2000 
(Thermoscientific) was used to assess yield and purity of extracted RNA. Primer 
sequences were designed using Primer 3 software (Table 2.1). The reaction 
efficiencies for each primer set were evaluated with standard curve using 2-fold 
serial dilutions of total RNA. cDNA synthesis from RNA and qRT-PCR were 
performed using SuperScript III Platinum SYBR Green One-Step qRT-PCR Kit 
(Invitrogen). Myosin Heavy Chain and Myogenin gene expression profiles were 
analyzed at day 0, 3 and 4. Reaction conditions were briefly as follows: 55 °C for 5 
min, 95 °C for 5 min, 40 cycles of 95 °C for 15 s, 60 °C for 30 s, and 40 °C for 1 
min, followed by a melting curve to confirm product specificity. For analysis of the 
expression data, primary gene expression data was normalized to the expression level 
of GAPDH. A comparative Ct method was used to analyze the results. Gene 
expression was normalized to GAPDH and TCP. 
Table 2.2 Primer sequences of myogenin and myosin heavy chain for C2C12 cells. 
Gene 
Primer Sequence: Forward/Reverse Annealing 
Temp. 
Myogenin 5’-ACCTTCCTGTCCACCTTCAG-3’ 
5’-CACCGACACAGACTTCCTCT-3’ 
58.5 ⁰C  
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Myosin Heavy Chain 5’-GGAGTACAAGAACGAGGGCA -3’  
5’-TTGAAGGAGGTGTCTGTCGC-3’  
 59.9 ⁰C 
 
 
2.2.6.3 Myosin Heavy Chain Immunocytochemical Staining 
Antibodies against Myosin heavy chain were used for immunocytochemistry as a 
late marker of myotube differentiation. C2C12 cells were seeded onto PA coated 
surfaces and glass surface (15 mm) at a density of 8 x 10
3
 cells/cm
2
. After 
reaching confluency, differentiation was induced with low serum medium. 
Medium was changed every day. Cells were fixed in 4% paraformaldehyde/PBS 
for 10 min and permeabilized in 0.1% Triton X-100 for 15 min. To reduce 
nonspecific binding, samples were incubated with 3% (w/v) bovine serum 
albumin/PBS for 2 h and treated with 10 µg/mL Myosin heavy chain primary 
antibody (R&D MAB4470) overnight at 4 °C. After overnight incubation with 
primary antibody, samples were incubated with Alexa Fluor 488 goat anti-mouse 
secondary antibody at 1:300 dilutions for 1 h at room temperature. Extensive 
washing with PBS was performed between each steps. All samples were 
counterstained with 1 μM To-PRO-3 (Invitrogen) and 1:500 diluted phalloidine in 
PBS for 20 min at room temperature and mounted with Prolong Gold Antifade 
Reagent (Invitrogen). Negative controls were obtained by omitting primary 
antibody and incubating with 1% normal goat serum/PBS. Samples were imaged 
using confocal microscope (Zeiss LSM510). 
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2.3 RESULTS AND DISCUSSION 
2.3.1 Sythesis and Characterization of Peptide Amphiphiles 
Four different peptide amphiphile molecules were designed and synthesized by solid 
phase peptide synthesis to form nanofibers which presents chemical groups in 
Laminin and Fibronectin structure. Peptide amphiphiles were designed as a 
composition of hydrophobic alkyl group, β-sheet driving group and charged group. 
Lauric acid added at the end of peptide gives a hydrophobic character to peptide 
amphiphile which triggers hydrophobic collapse during self-assembly. For β-sheet 
forming part, four non-polar aminoacids were used; Val-Val-Ala-Gly (VVAG). 
Laminin-derived sequence “IKVAV” (Lauryl-VVAGKKIKVAV-Am) and 
fibronectin-derived sequence “RGD” (Lauryl-VVAGERGD) were incorporated into 
peptide amphiphiles (LM-PA and FN-PA, respectively) to generate a 2D myogenic 
environment. As a counter negatively charged peptide amphiphile, E-PA (Lauryl-
VVAGE-OH) with only one glutamic acid after VVAG sequence was designed. LM-
PA is positively charged at pH 7.4 whereas FN-PA and E-PA are negatively charged. 
To form gel, positivley charged LM-PA was mixed with either FN-PA or E-PA so 
that two network was generated. One of them includes only “IKVAV” signal while 
other one presents both “IKVAV” and “RGD” signals. Also, to form non-bioactive 
control group, positively charged K-PA (Lauryl-VVAGK-Am) was synthesized 
adding lysine aminoacid to N-terminus of peptide amphiphile and mixed with 
negatively charged E-PA (Figure 2.1). 
2.3.1.1 Mass Spectrometry and HPLC Purification 
QTOF-LCMS was used to verify synthesized peptide amphiphiles accordingly. 
Expected masses for all PA molecules are 1291.93 for LM-PA, 983.57 for FN-PA, 
655.42 for E-PA and 653.48 for K-PA as shown in Table 2.2. We obtained 1292.97 
for LM-PA, 982.54 for FN-PA, 654.41 for E-PA and 654.50 for K-PA (Figure 2.2, 
and Figure 2.3).  
2.3.1.2 Circular Dichroism  
Circular Dichroism (CD) analysis was performed to understand the secondary 
structure of peptide amphiphiles. CD measures the differential absorbance of left- 
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Figure 2.1 Chemical structures of peptide amphiphile molecules, A) LM-PA, B) FN-
PA, C) E-PA and D) K-PA 
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Figure 2.2 Liquid Chromatography of A) LM-PA, B) FN-PA, C) E-PA and D) K-PA 
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Figure 2.3. Electrospray ionization mass spectra of A) LM-PA, B) FN-PA, C) E-PA 
and D) K-P
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handed and right-handed circularly polarized light which exhibited on optically 
active chiral molecules. The absorbance is provided by the amide group forming the 
peptide backbone by acting as a chromophore in the far UV region. While none of 
the PAs were found to display an ordered structure by itself, CD spectra of the PA 
mixtures revealed a minimum at 220 nm and a maximum at 200 nm, which indicate 
β-sheet secondary structure in both annealed and normal LM/FN-PA, LM/E-PA and 
E/K-PA combinations (Figure 2.4). 
2.3.1.3 Scanning Electron Microscopy 
To characterize self-assembly of peptide amphiphiles, nanofiber formation and 
morphology of the peptide network, SEM imaging was performed. SEM imaging 
reveals that nanofibers formed upon mixing oppositely charged peptide amphiphiles 
LM/FN-PA, LM/E-PA and E/K-PA. (Figure 2.5). These peptide networks with its 
porous and nanofibrous morphology, mimicks the physical architecture of native 
ECM of cell. 
2.3.1.4 Transmission Electron Microscopy 
TEM imaging was also performed to further analyze nanofiber formation and 
individual nanofibers. TEM images revealed that nanofibers formed upon charge 
neutrilization of oppositely charged peptide amphiphiles. Nanofibers were observed 
with 6 – 10 nm diameters and lengths up to a few microns (Figure 2.5). Moreover, 
bundling of nanofibers for E/K-PA was observed.  
2.3.1.5 Oscillatory Rheology 
Rheology experiment was applied to peptide nanofibers in order to analze gel 
formation upon mixing oppositely charged peptide amphiphiles. Gel formation is 
defined when storage modulus (G′) is higher than the loss modules (G′′) where a shift 
from viscous liquid to gel form is taken place. LM/FN-PA and LM/E-PA mixtures 
showed higher storage moduli (G′) than loss (G″) moduli, which was consistent with 
the formation of a gel. The 1% (wt/v) gels exhibited storage moduli of between 1-3 
kPa with loss moduli of 100-500 Pa. At the 0.1% strain, both LM/E-PA and LM/FN-
PA combinations were similar in terms of mechanical properties.  
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Figure 2.4 Characterization of peptide amphiphile molecules by using circular 
dichoism and oscillatory rheology. A) Secondary structure characterization of 
annealed and normal PA molecules with circular dichoism, and B) storage and loss 
moduli of PA mixtures prepared through annealing and without annealing procedure, 
to compare mechanical differences between standard and annealing protocol. 
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Figure 2.5 Characterization of peptide amphiphile molecules by using scanning 
electron microscopy and transmission electron microscopy. A) SEM images of 
LM/FN-PA and B) LM/E-PA and C) E/K-PA gels that reveal the ECM mimicking 
morphology (Scale bars = 3 µm). Representative TEM images of individual 
nanofibers of (D) LM/E-PA and E) STEM image of LM/FN-PA, and F) E/K-PA 
(Scale bars = 100 nm). 
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Annealed PA gels showed higher storage moduli than unheated PA gels, such that 
the mechanical strength of the bulk annealed gels were higher than their unheated 
counterparts (Figure 2.4).  
2.3.2 Cell Culture on Peptide Nanofibers  
2.3.2.1 Design of 2D Cell Culture Experiments 
Laminin and fibronectin mimetic  PAs were coated onto tissue culture plates and 
coverslips to determine the effect of chemical groups on PAs to the cellular 
behaviors such as viability, spreading, proliferation and differentiation in two-
dimensional cell culture. LM/E and LM/FN nanofibers were used to mimic basal 
lamina and E-PA/K-PA nanofibers were used as nan-bioactive control groups along 
with uncoated tissue culture plates which lack peptide nanofibers. C2C12 cells are 
used in all in vitro experiments due to their myoblast phenotypes and differentiation 
capacities.  
2.3.2.2 Biocompatibility of Peptide Nanonetworks 
Viability of myoblast cells was assessed with Calcein-AM staining. Calcein-AM is a 
cell-permeable and nonfluorescent dye which is converted into fluorescent calcein 
upon acetoxymethyl ester hydrolysis by intracellular esterases and gives green color. 
After 24 h of incubation in growth medium, cells on peptide nanofibers and tissue 
culture plates were stained with Calcein to utilize their viabilities. Calcein AM 
staining showed that LM/E-PA and LM/FN-PA nanofibers did not alter viability of 
C2C12 cells compared to uncoated tissue culture plate surface (Figure 2.6). 
Quantitative results of this viability assay was done by counting live and dead cells 
through Image J program and calculated by taking ratios of live cells to total number 
of cells. On LM/E-PA nanofiber networks, cells showed 97.31 % viability, whereon 
LM/FN-PA and TCP, 96.74% and 95.45% viability were calculated, respectively. 
This result demonstrated the biocompatibility of the PA system (Figure 2.6 D), 
which was further confirmed with microscopic observations of the morphologies of 
C2C12 cells. The spindle-like morphology of C2C12 cells was preserved during their 
culturing on LM/E-PA and LM/FN-PA nanofibers. Figures and quantitative results 
indicates that basal lamina mimetic peptide nanofibers do not have any toxic affect 
on cells and they provide biocompatible and biofriendly environments where cells 
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can live. However, cells cultured on a non-bioactive control peptide amphiphiles 
(E/K-PA) displayed decreased viability and clustering (Figure 2.7). Consequently, 
this combination was not used for further experiments. Overall, cellular viability was 
supported on bioactive peptide nanofibers and it was comparable with TCP, which 
indicates the biocompatibility of LM/E-PA and LM/FN-PA  peptide nanofibers. 
2.3.2.3 Adhesion and Proliferation of cells 
Cell adhesion is mediated through interaction of cell surface proteins with ligands 
present in the proteins of the ECM. IKVAV and RGD are ligands found in ECM and 
binds to cells through cell surface receptors. We investigated the initial adhesion 
behavior of cells to the nanofibrous networks in the absence of any adhesion 
proteins, and by preventing cells from synthesizing new  
adhesion proteins via cyclohexamide. After 2 h of adhesion, cells were stained with 
Calcein-AM and observed under fluorescent microscope and number of adhered cells 
was count on Image J. Results showed that cells on LM/FN-PA surfaces adhere 
slightly better than other groups, though this difference was not statistically 
significant. Quantified data showed that adhesion of cells to peptide amphiphile 
nanofibers were comparable with tissue culture plate results (Figure 2.8 D). 
Proliferation profiles of cells on peptide nanofibers were assessed with BrdU 
incorporation assay. 5-bromo-2-deoxyuridine (BrdU) is a uridine derivative and a 
structural analog of thymidine and it can be incorporated into DNA during the 
synthesis-phase of the cell cycle as a substitute for thymidine, thereby serving as a 
marker for proliferation. After 48 h of incubation in growth medium, cells on 
LM/FN-PA coated surfaces proliferated significantly more than cells on LM/E-PA 
coated surfaces (Figure 2.8 E). This increase in proliferation is likely due to the 
additional effect of RGD. No significant difference in proliferative capacity was 
found between the LM/E-PA system and TCP. These results show that this fibrous, 
ECM-mimetic peptide amphiphile system provides a biocompatible and favorable 
environment for the growth and proliferation of C2C12 cells. 
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Figure 2.6 Viability of C2C12 cells on peptide nanofiber networks. Live-dead assay 
of C2C12 cells at 24 h.  Dead cells were stained red and live cells were stained green. 
The scale bar is 200 µm in all images. (A) LM/E-PA, (B) LM/FN-PA and (C) TCP. 
(D) Relative viability of C2C12 cells on LM/FN-PA and LM/E-PA coated surfaces 
compared to tissue culture plate surface at 24 h 
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Figure 2.7 Cellular viability and proliferation of C2C12 cells on control peptide 
group. A) Optical microscope image of C2C12 cells on E/K-PA coating, 10x 
objective, B) live (green) and dead (red) cells stained with live/dead assay, C) 
quantitative analysis of viability assay  and D) proliferation of cells cultured in E/K-
PA.  
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Figure 2.8 Adhesion and proliferation of C2C12 cells on peptide nanofiber networks. 
Fluorescence images of 2 h adhesion assay, A) C2C12 cells on LM/E-PA, B) 
LM/FN-PA and C) TCP and D) Relative adhesion of C2C12 cells normalized to 
TCP. E) Relative proliferation of cells normalized to TCP at 48 h. Error bars 
represent mean ± SEM (*p<0.05). 
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2.3.2.4 Morphology of Differentiated Cells 
After induction of differentiation, morphology of the cells were checked every day 
under optical microscope. Significant changes in cell morphology were observed 
during the differentiation process since individual myoblast cells contact with each 
other and fuse to form multinucleated, long myotubes. Fusion of the cells was 
evident within 2 days, and the formation of elongated myotubes was observed after 3 
days of incubation with reduced serum medium. Since myotubes have a tendency to 
delaminate from the surface after long-term incubation, quantitative analyses were 
done at day 3 and 4 to minimize the detachment of cells from the surface. Optical 
microscopy images clearly showed the formation of myotubes (Figure 2.9) after 3 
days of incubation. Myotube lengths, diameters and numbers were also evaluated 
with light microscopy to quantitatively describe myotube morphology and 
development. Average myotube lengths were around 250 μm, albeit with a wide 
distribution range between 150-600 μm. While the cells cultured on LM/E-PA 
produced a greater number of myotubes compared to cells on TCP, differences 
regarding myotube numbers, lengths and diameters were not statistically significant 
between the groups. As such, all groups showed similar profiles in terms of 
quantitative myotube properties (Figure 2.10). 
2.3.2.5 Gene Expression analysis 
The expression of skeletal muscle differentiation markers was investigated by qRT-
PCR to further analyze skeletal myogenesis, as well as to understand the effect of 
peptide amphiphile nanofibers on the expression of vital muscle differentiation 
genes. Myogenin is one of the myogenic transcription factors, and plays a key role in 
later stages of myogenesis. qRT-PCR analysis showed that myogenin expression 
increased significantly on LM/E-PA coated surfaces compared to TCP at day 3, 
although there was no significant difference between the expression levels of LM/E-
PA and LM/FN-PA groups. However, at day 4, LM/E-PA group had a significantly 
higher expression of myogenin (2.46 fold relative to TCP)  than both TCP and 
LM/FN-PA (Figure 2.11 A, B). This could be due to the presence of the proliferative 
RGD sequence on LM/FN-PA. Myosin heavy chain (MHC) is another late myogenic 
differentiation marker, of which expression was analyzed with qRT-PCR. MHC is an 
important protein for sarcomeric organization of differentiated myotubes. In parallel  
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Figure 2.9 Bright-field images of C2C12 cells cultured on peptide nanofiber 
networks after 3 days and 4 days of myogenic induction. (Scale bars = 200 µm) 
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to myogenin expression, upregulation in MHC was also observed in LM/E-PA group 
compared to other groups, though it is not significant at both days 3 and 4 (Figure 
2.11 C, D). 
2.3.2.6 Immunocytochemical Staining 
Myotubes were stained for sarcomeric myosin heavy chain expression to characterize 
and further confirm myogenic differentiation following culturing on bioactive 
peptide nanofibers at day 4. The differentiation of C2C12 cells toward mature 
skeletal muscle cells was evaluated by the analysis of stained cells. Confocal 
microscopy images showing MHC-positive differentiated cells (green) and nuclei 
(red) are shown in Figure 2.12. These results are in good agreement with the 
previous results, where MHC positive myotubes can be observed in all three groups. 
Myogenic fusion index, a metric reflecting the number of fused cells per total cell 
number, was calculated for all groups and found to be ca. 15% at day 4, with only 
slight differences between the groups (Figure 2.13). Maturation index, which denotes 
the prevalence of myotubes with 5 or more nuclei compared to total myotube 
numbers, was also measured. Roughly 30% of all myotubes were found to be mature 
in each group.  
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Figure 2.10 The relative myotube number, average length and diameter quantified 
with Image J. Error bars represent mean ± SEM. 
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Figure 2.11 Gene expression analyses of C2C12 cells cultured on nanofiber networks 
after myogenic induction. A) Myogenin expression at day 3, B) Myogenin 
expression at day 4, C) Myosin Heavy Chain (MHC) expression at day 3, D) 
Myogenin expression at day 4. The expression level of each gene was normalized 
against TCP and GAPDH was used as the internal control. Error bars represent mean 
± SEM, (*p<0.05). 
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Figure 2.12 Representative immunofluorescent staining of Myosin Heavy Chain (MHC) and nuclei of myotubes 4 days after myogenic 
induction on the peptide nanofibers A) LM/E-PA, B) LM/FN-PA, and C) TCP. Green: MHC, Red: Nucleus. (Scale bar = 20 µm) 
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2.4 Conclusion 
Bioactive peptide nanofiber based systems are effective materials for providing 
myogenic signals to augment muscle regeneration while simultaneously preventing 
the infiltration of connective tissue. The flexible nature of these systems allows the 
utilization of multiple strategies under both mechanical and biochemical channels. In 
this study, a peptide-based bioactive nanofiber system was used to create a favorable 
microenvironment with its fibrous architecture and biochemical signals for myogenic 
induction of skeletal myoblast cells. This system was developed to be bioactive and 
biocompatible, and was composed of self-assembled nanofibers functionalized with a 
myogenic inductive sequence and an adhesion sequence inspired from native basal 
lamina of skeletal muscle tissue. The presence of laminin-derived signals, in 
conjunction with the fibrous morphology of the nanofiber network, provides the 
chemical and structural support necessary for the differentiation of C2C12 cells, 
while the nanofibrous morphology by itself was not sufficient for neither cell 
adhesion nor cell viability. Our results showed that C2C12 cells remained viable and 
proliferative on both of the bioactive peptide nanofiber scaffolds, LM/FN-PA and 
LM/E-PA, following induction by decreasing serum concentrations supplemented 
with insulin, cells differentiated into elongated, multi-nucleated myotubes with 
myogenin and myosin heavy chain expression. Such properties indicate the 
myogenic potential of these platforms and reveal their potency for muscle 
regenerative medicine. Due to its biocompability, biodegradability and the ease of 
delivery by injection, our laminin derived signal-incorporating peptide amphiphile 
system offers a promising platform for future clinical applications. 
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Figure 2.12 The relative fusion index and maturation index were calculated from 
images as reported in materials and methods. Error bars represent mean ± SEM. 
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CHAPTER 3. ANGIOGENIC PEPTIDE NANOFIBERS FOR 
CARDIOMYOCYTE DIFFERENTIATION 
Part of this study will be submitted to be published as “Angiogenic Peptide 
Nanofibers Repair Cardiac Tissue Defect After Myocardial Infarction” Rufaihah 
Abdul Jalil, İmmihan Ceren Garip, Srirangam Ramanujam Vaibavi, Suganya 
Cheyyatraivendran Arularasu, Theo Kofidis, Mustafa O. Guler, Ayse B. Tekinay. 
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3.1      INTRODUCTION 
Heart failure is one of the most common causes of death worldwide, and current 
therapies only delay the progression of the disease. Coronary heart disease is 
characterized by reduced blood supply to the heart and leads to myocardial infarction 
(MI), which causes apoptosis or necrosis in cardiomyocytes. Arrested blood and 
oxygen flow to the myocardium irreversibly damages the heart and causes 
pathological remodeling, myocardial loss, cardiac dysfunction and heart failure 
116
. 
Current therapies include pharmacological therapy and percutaneous coronary 
intervention or coronary artery bypass surgery. However, the limited efficiency of 
current medical treatments generally results in final stage heart failure in several 
cases and these heart failure patients require heart transplantation (with limited 
availability) or the support of ventricular assisted devices, which have limited 
efficacy 
117
. Therefore, the development of novel therapeutic strategies to regenerate 
lost myocardium could help millions of patients every year. Tissue engineering and 
regenerative medicine approaches are currently under investigation by many research 
groups for the potential repair of damaged myocardial tissues.  
Cell therapy offers the promise of rebuilding the injured heart through a process 
similar to the one that is effective during natural tissue regeneration, and rapid 
translation of cell-based approaches to the clinic suggests that cell-based therapies 
can genuinely improve cardiac function. The mobilization of cells with factors such 
as cytokines is another related strategy for cardiac repair. However, many challenges 
still remain in stem cell-oriented therapeutic approaches and the optimal type of cell 
for many treatments have yet to be determined 
65
. The optimal route of delivery and 
the long term survival and stability of the cells in the infarct area are other concerns 
related to cell-based therapies. Some of the current research focuses on improving 
our ability to guide the differentiation of stem cells, control their environment and 
deliver them in a suitable scaffold to increase the efficiency of the therapy. Another 
challange is the requirement for vascularization, as persistent ischaemia limits cell 
survival. Consequently, revascularization and enhanced angiogenesis are essential 
components of stem cell-based therapies. It was shown that induction of 
angiogenesis is a vital mechanism that may alleviate cardiac function after MI 
118-119
. 
Cells located at a distance of 200 µm from the capillaries were shown to benefit from 
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the oxygen and nutrient transport, while cells that are located further away, are under 
oxygen and nutrient stress.  
Heparan sulphate (HS) chains interact with a variety of proteins, including growth 
factors/morphogens and their receptors, chemokines, and ECM proteins. Interactions 
of HS with proteins vary with regard to their specificity, which often depends heavily 
on charge density rather than the carbohydrate sequence 
120
. These interactions 
influence important processes in development, homeostasis and disease. In addition, 
HS is known to modulate the interaction of proangiogenic heparin-binding vascular 
endothelial growth factors and affect their bioavailability and interaction with VEGF 
receptor-2 (VEGFR2) and neuropilin co-receptor in endothelial cells 
121-122
. As such, 
it is well established that HS plays a key role in vascularization and may serve as a 
potential target for biomimetic strategies.  
Peptide-based scaffolds are suitable candidates for designing biomaterials to be used 
in tissue engineering applications, as they are biocompatible and display the ability to 
incorporate various bioactive chemical groups in their sequence. Peptide amphiphile 
molecules, with their adaptive nature and ability to self-assemble into nanostructures 
with highly variable properties, are high-fidelity models for studying the effects of 
bioactive and fibrous scaffolds on cellular differentiation. These nanofibers self-
assemble into nanofibrous gels at physiological pH. Peptide nanofibers have the 
advantages of being biodegradable, hypo-immunogenic and suitable for sustained 
release of a growth factor through covalent bonding. Previously, we have developed 
a heparan sulphate-mimetic peptide amphiphile nanofiber scaffold which interacts 
with growth factors secreted by cells and induces angiogenesis without the addition 
of exogenous growth factors 
98
. Through an innovative design, these heparin-mimetic 
peptide amphiphiles were decorated with sulphonate, hydroxyl and carboxylic acid 
groups in order to mimic heparan sulphate glycosaminoglycans, which are 
fundamental constituents of the extracellular matrices of many tissues.  
This chapter discusses the in vitro effect of heparan sulphate-mimetic peptide 
nanofibers on the differentiation of cardiomyocytes for the purpose of generating a 
bioactive material which can repair damaged myocardium and induce angiogenesis. 
Peptide nanofibers used in this study provide a biochemically and morphologically 
suitable surface for H9C2 myoblast to adhere, thereby enhancing their survival and 
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differentiation. Below, we described the design and characterization of peptide 
nanofibers and their effects on myogenic behaviours.  
3.2      EXPERIMENTAL 
3.2.1 Chemicals and Solutions 
9-Fluorenylmethoxycarbonyl (Fmoc) and tert-butoxycarbonyl (Boc) protected 
amino acids, [4-[α-(2’,4’-dimethoxyphenyl)Fmoc-aminomethyl] phenoxy] 
acetamidonorleucyl-MBHA resin (Rink amide MBHA resin), 2-(1H-
Benzotriazol-1-yl)-1,1,3,3 tetramethyluronium hexafluorophosphate (HBTU) and  
lauric acid were purchased from NovaBiochem, ABCR and Merck. Piperidine, 
acetic anhydride, dichloromethane (DCM) and dimethylformamide (DMF), N, N-
diisopropylethylamine (DIEA), trifluoroacetic acid (TFA): triisoproplysilane 
(TIS) were purchased form Sigma. 
Cell Culture Reagents: 
Dulbecco’s Modified Eagle Medium (DMEM), penicillin/streptomycin (PS) 
antibiotic combination and fetal bovine serum (FBS) were purchased from 
Invitrogen Gibco.  
3.2.2 Synthesis of Glycosaminoglycan-mimetic Peptide Amphiphiles 
To synthesize glycosaminoglycan-mimetic peptide amphiphiles, solid phase peptide 
synthesis was performed with standard Fmoc chemistry. Rink Amide MBHA resin or 
Fmoc-Glu (OtBu)-Wang resin was used as template where amino acids were added 
on. Amino acid couplings were performed as 2 equivalents of amino acids activated 
with 1.95 equivalents of HBTU and 3 equivalents of DIEA for 2 h. To remove Fmoc 
protection groups, 20% piperidine–DMF solution was used for 20 min. To 
permanently acetylate the unreacted amine groups after each coupling step 10% 
acetic anhydride–DMF solution was used. DMF and DCM were used as washing 
solvents after each step. To synthesize sulfonated PAs, p-sulfobenzoic acid was 
added to the side chain of lysine which has 4-methytrityl (Mtt) side chain protection 
as used for selective deprotection of amine groups. Mtt removal was performed by 
shaking resin for 5 min with TFA:TIS:H2O:DCM in the ratio of 5:2.5:2.5:90. 
Cleavage of the PAs and protection groups from the resin was performed by using a 
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mixture of TFA: TIS: H2O in the ratio of 95:2.5:2.5 for 3 h. Rotary evaporation was 
used to remove excess TFA from the peptide solution. PAs in the remaining solution 
were precipitated in ice-cold diethyl ether overnight. Next day, the precipitate was 
collected by centrifugation and dissolved in ultrapure water. This solution was frozen 
at -80 °C for 4 h and then lyophilized for 4-5 days. 
3.2.3 Purification of Peptide Amphiphiles 
To characterize synthesized peptide amphiphiles, a quadruple time of ﬂight (Q-TOF) 
mass spectrometer with electrospray ionization (ESI) source equipped with a reverse-
phase analytical high performance liquid chromatography (HPLC) was used. Agilent 
Zorbax Extend-C18 2.1 x 50 mm column was used for negatively charged peptide 
molecules and Zorbax SB-C8 4.6 x 100 mm column was used for positively charged 
peptide molecules, respectively. A gradient of water (0.1% formic acid and 0.1% 
NH4OH) and acetonitrile (0.1% formic acid and 0.1% NH4OH) were used for liquid 
chromatography. In order to purify synthesized peptide amphiphiles, reverse-phase 
preparative HPLC equipped with Zorbax Extend-C18 21.2 x 150 mm column for 
negatively charged peptide molecules and Zorbax SB-C8 21.2 x 150 mm column for 
positively charged peptide molecules was used. A gradient of water (0.1% 
acetonitrile and 0.1% NH4OH) and acetonitrile (0.1% formic acid and 0.1% 
NH4OH) were used. Furthermore, positively-charged peptide amphiphiles were 
treated with 0.1 M HCl solution in order to remove residual TFA at the end. 
3.2.4 Characterizations of Self-Assembled Peptide Nanostructures 
Chemical and mechanical characterizations of peptide amphiphiles were performed 
using SEM, TEM, CD, and rheology.  
3.2.4.1 Circular Dichroism 
To analyze secondary structures of PA molecules CD (JASCO J815 CD 
spectrapolarimeter) was used. 2 x 10
-4
 M concentration was used to mix GAG-PA 
and K-PA. Secondary structures of individual PA molecules were also analyzed at 2 
x 10
-4
 M concentration. All measurements were performed with three accumulations 
from 300 nm to 190 nm wavelengths using a digital integration time of 1 s, a band 
width of 1 nm and with standard sensitivity. Quartz cuvettes with 1 mm path length 
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were used for measurements. Molar elipticity was calculated with the data obtained 
from measurements. 
3.2.4.2 Scanning Electron Microscopy 
To visualize nanofiber formation upon self assembly of peptide amphiphiles, SEM 
and TEM imaging were performed. For SEM imaging 30-40 µL of 10 mM PA 
mixtures (GAG-PA/K-PA and E-PA/K-PA) were placed onto silicon wafers and 
critical point dried after dehydrating sequentially in 20%, 40%, 60%, 80% and 100% 
ethanol. After gradual ethanol dehydration, gels were dried by using critical point 
dryer (Tousimis, Autosamdri-815B, Series C critical point dryer) and coated with 5 
nm Au/Pd before imaging. Then, morphological properties of the PA gels were 
observed with SEM, FEI Quanta 200 FEG with ETD detector at high vacuum mode 
at 10 keV beam energy.  
3.2.4.3 Transmission Electron Microscopy 
For TEM analysis, 1 mM GAG-PA was mixed with 2 mM K-PA in equal volumes. 
After 5 min self-assembly, it was diluted 5 times and put on a 200-mesh carbon TEM 
grid for 1 min followed by 2 wt% uranyl acetate staining for 40 s and drying under 
flow hood. Imaging was performed using FEI Tecnai G2 F30 transmission electron 
microscope with TEM and STEM mode.  
3.2.4.4 Oscillatory Rheology 
Oscillatory Rheology (Anton Paar Physica RM301 rheometer) operating with a 25 
mm parallel plate configuration at 25 ºC was used to investigate the mechanical 
properties of GAG-PA/K-PA gel. 10 mM GAG-PA and K-PA with a total volume of 
250 μL were loaded on the center of the plate and measurement was done with 0.5 
mm gap distance, 100 - 0.1 rad/s angular frequency and 0.1% shear strain.  
3.2.5 Cell Culture 
H9c2 cells derived from embryonic rat ventricle were a kind gift from Gazi 
University, Ankara, Turkey. Cells were cultured in a humidified, 37 °C, 5% CO2 
incubator using 75 cm
2
 polystyrene cell culture tissue flasks containing High Glucose 
DMEM supplemented with 15% fetal bovine serum (FBS), 1% 
penicillin/streptomycin (P/S) and 4 mM L-glutamine. Passaging of cells was carried 
out at cell confluence between 50 to 60% to save myoblastic population, using 
trypsin/EDTA. Cells were diluted 1:4 for subculturing. Differentiation induction was 
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carried out after cells became 80% confluent by adding high glucose DMEM 
supplemented with 1% FBS, 1% penicillin/streptomycin and 10 nM retinoic acid 
(RA, Sigma–Aldrich). In all experiments, media were changed every 2 days. 
In vitro tests in this study were carried out on GAG-PA/K-PA coated well plates and 
cover slips unless otherwise mentioned. Coating was done by mixing PA molecules 
in equal volume with 1 mM and 2 mM concentration after pH adjustment and 
sonication. Before coating process, solutions were sterilized under UV for at least 1 
h.  Gel formation was achieved at 37 °C for 30 min and drying was performed under 
laminar flow hood overnight. Before experiments, dried plates were further sterilized 
under UV light for 1 h and washed with PBS to remove unbound nanofibers. 
3.2.5.1 Cell Viability and Adhesion   
Cell viability on the surface of nanofibers was tested with Alamar Blue viability 
assay.  In this experiment, 3 different charges were tested and negatively, neutral and 
positively charged combinations were formed by mixing GAG-PA (1 mM) and K-
PA with varying molar ratios (1:2, 1:3 and 1:4). Coated 96 well-plates were used for 
analysis and H9C2 cells were seeded at a density of 5 x 10
3
 cells/well. After 24 h of 
standard incubation, Alamar Blue reagent was diluted 1:10 with serum-free medium 
and replaced with standard medium. After subsequent 4 h of incubation, absorbance 
was measured using microplate reader at 570 nm and 600 nm background. We 
continued with -1 charge combination (1:2 ratios) for further experiments. 
Cell adhesion was performed under serum-free conditions. Cells were incubated for 
1 h in serum free DMEM medium supplemented with 4 mg/mL Bovine Serum 
Albumin (BSA) and 50 mg/mL cyclohexamide at standard culture conditions before 
seeding. After 1 h, cells were removed from tissue culture plate by trypsinization and 
seeded onto the coated 96 well plates at a density of 5 x 10
3
 cells/well. After 2 h of 
incubation in serum-free medium at standard culture conditions, Calcein AM 
(Invitrogen) staining (2 μM) was performed for 40 min according to the 
manufacturer’s instructions. Cell adhesion was quantified directly by counting the 
number of cells using Image J (NIH) program from the images taken with fluorescent 
microscope. Images were taken from 4-5 different locations per well, and experiment 
was carried out with n=4. Results were then normalized to uncoated tissue culture 
plate. 
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3.2.5.2 Cell Proliferation 
Proliferation of cells on GAG-PA/K-PA coating was assessed using BrdU assay after 
72 h. Cells were seeded onto PA coated wells (1:2 molar ratio) and tissue culture 
plates (TCP) at a density of 3 x 10
3
 cells/well. Cells were incubated in standard cell 
culture conditions for 72 h. 2 h prior to the experiment, cell medium was replaced 
with 10 µM BrdU labeling solution-containing standard maintenance medium. At the 
end of the time, BrdU incorporation assay was performed according to 
manufacturer’s instructions. Briefly, cells were fixed with FixDenat for 30 min and 
after that anti BrdU-POD solution was added into wells. Following 90 min of 
incubation and tapping, substrate solution was added into wells and proliferation 
rates of the cells were quantified by measuring absorbance (370 nm, with 492 nm 
reference wavelength) with a microplate reader. 
3.2.6 Gene Expression Analysis  
Quantitative RT-PCR (qRT-PCR) analysis was used for gene expression analysis. 
Total RNA was isolated from C2C12 samples using TRIzol (Invitrogen) reagent. 
Nanodrop 2000 (Thermo scientific) was used to assess yield and purity of extracted 
RNA. Primer sequences were designed using Primer 3 software. The reaction 
efficiencies for each primer set were evaluated with standard curve using 2-fold 
serial dilutions of total RNA. 
cDNA synthesis from RNA and qRT-PCR were performed using SuperScript III 
Platinum SYBR Green One-Step qRT-PCR Kit (Invitrogen) according to 
manufacturer’s instructions. Ventricular myosin light chain-2 (Mlc-2v) and 
Myogenin genes’ expression patterns were analyzed at day 0, 3 and 4. Reaction 
conditions were briefly as follows: 55 °C for 5 min, 95 °C for 5 min, 40 cycles of 95 
°C for 15 s, 60 °C for 30 s, and 40 °C for 1 min, followed by a melting curve to 
confirm product specificity. For analysis of the expression data, primary gene 
expression data were normalized by the expression level of GAPDH. A comparative 
Ct method was used to analyze the results. Gene expression was normalized to 
GAPDH and TCP. 
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Table 3.1 Primer sequences and annealing temperatures with efficiencies 
Gene Primer Sequence: Forward/Reverse Annealing Temp. 
Myogenin 5’ TGGTCCCAACCCAGGAGATC 3’ 
5’ AGAAGTGGTGGCGTCTGA C 3’ 
60 ⁰C  
 
Mlc-2v 5’ CCTGACGTCACCGGCAACC 3’ 
5’ TGGGTGATGATGTGAACCAAA 3’ 
54 ⁰C 
 
 
3.2.7 Immunocytochemical Staining 
Cardiac Troponin T was stained as a marker of cardiomyocyte differentiation. H9C2 
myoblast cells were seeded onto PA coated surfaces and glass surface (15 mm) at a 
density of 1.5 x 10
4
 cells/well. Differentiation was induced after reaching 
confluency. Medium was exchanged every day. For immunocytochemistry, cells 
were fixed in 4% paraformaldehyde/PBS for 10 min and permeabilized in 0.1% 
Triton X-100 for 15 min. To reduce nonspecific binding, samples were incubated 
with 3% (w/v) bovine serum albumin/PBS blocking reagent for 2 h and treated with 
1:200 diluted Cardiac Troponin T primary antibody (Ms Ab33589) overnight at 4 °C. 
After overnight incubation with primary antibody, samples were incubated with 
Alexa Fluor 488 goat anti-mouse secondary antibody at 1:300 dilution for 1 h at 
room temperature. Extensive washing with PBS was performed between each step. 
All samples were counterstained with 1 μM TO-PRO-3 (Invitrogen) and 1:500 
diluted phalloidine in PBS for 20 min at room temperature and mounted with 
Prolong Gold Antifade Reagent (Invitrogen). Negative controls were obtained by 
omitting primary antibody and incubating with 1% normal goat serum/PBS. Samples 
were imaged by using confocal microscope (Zeiss LSM510). 
3.3      RESULTS AND DISCUSSION 
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3.3.1 Self-assembly and Characterization of Peptide Amphiphiles 
Peptide amphiphile molecules used in this study, lauryl-VVAGEGD-K (p-
sulphobenzoyl)-S-Am (GAG-PA) and lauryl-VVAGK-Am (K-PA) (Fig.3.1A and 3.1 
B), were synthesized by solid phase peptide synthesis method and at physiological 
pH. Heparin-mimetic PA (GAG-PA) has a net charge of -3, whereas lysine-PA (K-
PA) has a net charge of +1 at physiological pH (Figure 3.1).  QTOF-LC/MS was 
used to verify synthesized peptide amphiphiles accordingly and observed mass of 
PAs as shown in Figure 3.2. 
3.3.1.1 Circular Dichroism 
Circular Dichroism (CD) analysis was performed to understand the secondary 
structure of peptide amphiphiles. None of the PAs were found to display an ordered 
structure by itself, while CD spectra of the PA mixtures revealed a minimum at 220 
nm and a maximum at 200 nm, which indicate β-sheet secondary structure in GAG-
PA/K-PA combination (Figure 3.3).  
3.3.1.2 Zeta Potential Measurement 
To determine the charge of the PA solutions and the system, zeta potential 
measurements were performed. GAG-PA was found to display a negative potential, 
while K-PA had a positive zeta potential. Self-assembled nanostructures formed 
upon mixing oppositely charged GAG-PA and K-PA revealed overall negative 
potentials (Figure 3.3 B). 
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Figure 3.1 Chemical structures of peptide amphiphile nanofibers used in this study. Chemical structure of A) GAG-PA and B) K-PA
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Figure 3.2 LC-MS chromatograms and electrospray ionization mass spectra of K-PA 
and GAG-PA. Liquid chromatography and Mass spectroscopy analysis of A, C) K-
PA and B, D) GAG-PA. 
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Figure 3.3 Characterization of PA molecules, A) circular dichroism spectra of PA 
molecules showing the β-sheet structure and B) zeta potentials of individual and 
mixed PA molecules. 
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3.3.1.3 SEM 
To characterize self-assembly of peptide amphiphiles, nanofiber formation and 
morphology of the peptide network, SEM imaging was performed. SEM imaging 
revealed that nanofibers formed upon mixing oppositely charged peptide amphiphiles 
GAG-PA and K-PA (Figure 3.4). These peptide networks with its porous and 
nanofibrous morphology, mimic the physical architecture of native ECM of cells.  
3.3.1.4 TEM 
TEM imaging was also performed to further analyze nanofiber formation and 
individual nanofibers. TEM images revealed that nanofibers formed upon charge 
neutralization of oppositely charged peptide amphiphiles. Nanofibers were observed 
with 6 – 10 nm diameters and lengths up to a few microns (Figure 3.4).  
3.3.1.5 Oscillatory Rheology  
Rheology experiment was applied to peptide nanofibers in order to analyze gel 
formation upon mixing oppositely charged peptide amphiphiles. GAG-PA and K-PA 
mixture showed higher storage moduli (G′) than loss (G″) moduli, which was 
consistent with the formation of a gel. At 10 mM concentration, the gels exhibited 
storage moduli between 5-6 kPa and loss moduli between 300-400 Pa (Figure 3.5). 
Also, at coating concentration, the gel behavior was observed where storage moduli 
were higher than loss moduli. 
3.3.2 Cell Culture on Peptide Nanofibers 
To investigate the effect of Heparan sulphate mimicking peptide nanofiber system on 
cellular behavior, H9C2 myoblasts, derived from rat myocardia, were seeded on 
peptide coated surfaces or tissue culture plates. For viability analysis, GAG-PA and 
K-PA molecules were mixed in different molar ratios to display positive, neutral and 
negative final charges on different wells. 
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Figure 3.4 Morphological properties of PA molecules analyzed with electron 
microscopy. A) SEM and B) STEM images revealed the nanofibrous network that 
mimic the native matrix architecture. 
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Figure 3.5 Mechanical characterization of peptide amphiphile network at 10 mM and 
1 mM concentration by oscillatory rheology. A) Storage and loss moduli of PA 
system and frequency and strain sweep of 10 mM PA network showing the behavior 
of gels under varying strain/stress amplitudes and strain, respectively. B) Storage and 
loss moduli of 1 mM PA mixture showing the gel characteristic of the system and 
frequency and amplitude sweep tests results. 
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3.3.2.1 Biocompatibiblity of Peptide Nanonetworks 
Viability of H9C2 after culturing for 24 h on bioactive peptide nanofibers was 
analyzed by Alamar Blue assay, and the results showed that peptide nanofiber 
network did not alter the viability of the cells compared to tissue culture plates and 
GAG/K-PA system is biocompatible with H9C2 cells at all three charge 
combinations (Figure 3.6). Cellular morphology was observed under optical 
microscope which further confirmed the viability results and showed that native cell 
morphology of H9C2 cells was preserved on PA-coated surfaces. In other 
experiments, molar ratios of mixtures were adjusted to yield a system with a net 
negative charge, matching the system utilized in our previous study on peptide-
mediated angiogenesis. Proliferation capability of H9C2 cells on peptide nanofibers 
was analyzed by BrdU assay, and the results showed that the proliferation of cells on 
PA nanofibers was slightly less than these on tissue culture plates, but the difference 
between the groups was not statistically significant (Figure 3.6 B). 
3.3.2.2 Adhesion of cells 
We also investigated the initial adhesion behavior of H9C2 cells on heparan sulphate 
mimetic bioactive peptide nanofiber networks in the presence of BSA and the 
translation inhibitor cyclohexamide, which minimize the interference of endogenous 
proteins with the adhesion process. After 2 h of incubation, both the qualitative 
observation of Calcein AM staining (Figure 3.7) and quantitative data derived from 
the staining results demonstrated that cells adhered to the GAG/K-PA coated surface 
slightly more than TCP.  
3.3.2.3 Gene Expression analysis 
The H9C2 cells seeded on peptide nanofiber networks were induced to differentiate 
under reduced serum concentrations, accompanied by daily treatment with 10 nM 
all-trans-retinoic (RA) acid to stimulate cardiomyocyte differentiation, as RA has 
been known to affect the differentiation of cardiomyocytes, among other cell types.  
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Figure 3.6 A) Viability of H9C2 cells cultured on GAG/K-PA coated surfaces and 
tissue culture plates at 24 h compared  to TCP analyzed by Alamar Blue assay, B) 
relative proliferation of H9C2 cells normalized to TCP at 72 h, analyzed with BrdU 
incorporation. 
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Figure 3.7 Adhesion of H9C2 cells cultured on GAG/K-PA coated surfaces and 
tissue culture plates. A) Representative Calcein-Am stained fluorescent images of 
adhered H9C2 cells on GAG/K-PA and TCP at 2 h, B) Relative adhesion of H9C2 
cells to PA nanofibers at 2 h with respect to TCP. 
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The expression of cardiac specific marker ventricular myosin light chain 2 (Mlc-2v) 
and skeletal myogenic factor myogenin was analyzed by qRT-PCR to investigate the 
differentiation profiles of H9C2 cells towards the cardiomyocyte phenotype. Cells, 
which were seeded on bioactive peptide nanofibers and incubated in differentiation 
medium, showed higher Mlc-2v expression than the cells grown on TCP control at 
day 7. Culturing GAG/K-PA coated surfaces increased the expression of this 
cardiomyocyte differentiation marker earlier than the control system (Figure 3.8 A). 
In addition, there was no increase in the expression of the skeletal muscle marker 
myogenin when the experimental groups were compared (Figure 3.8 B). These 
results showed that the heparan sulphate mimetic PA nanofiber system induces 
cardiomyocyte differentiation of cardiac myoblast cells. When the cells were 
cultured on GAG/K-PA coating and induced with 2% FBS supplemented with 10 nM 
RA, their Mlc-2v expression increases ca 15 fold, compared to cells which were 
grown in growth medium. Therefore, from the expression profile we understood that, 
with additional effect of RA, cells on GAG/K-PA differentiate into cardiomyocyte 
while in growth medium they keep their myoblastic behavior (Figure 3.8 C).  
We also analyzed the expression levels at day 10, but the expression of Mlc-2v was 
instead lower than that displayed by cells grown on TCP at day 10. This effect can be 
attributed to delayed differentiation of cells on TCP group compared to the PA 
nanofiber system. 
3.3.2.4 Immunocytochemical Staining 
Differentiation of H9C2 cells into cardiomyocytes was also investigated by 
analyzing the expression of cardiac troponin T (cTnT). The cTnT is an important 
cardiac-specific protein, and plays a role in cardiac muscle contraction and 
relaxation. Differentiated cardiomyocytes on heparin mimetic peptide nanofibers 
exhibited sarcomeric organization, observed through phalloidin staining after cells 
were cultivated in differentiation medium for 10 days. Also cTnT-positive 
(differentiated) cells were present on both GAG/K-PA coated surfaces and tissue 
culture plates (Figure 3.9) while cells incubated in growth medium did not reveal any 
staining for cTnT (Figure 3.10). SEM images also showed the normal morphology 
and size of cells incubated in growth medium.  
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Figure 3.8 Gene expression analysis of Mlc-2v and myogenin. A) qRT-PCR analysis 
of cardiac differentiation marker, Mlc-2v in H9C2 cells incubated for 7 and 10 days 
in the presence of 10 nM RA, results were normalized to GAPDH and compared to 
TCP. B) Expression of Mlc-2v when the results were normalized to GAPDH and 
compared with Mlc-2v expression in growth medium. PA nanofiber system along 
with RA increases gene expression ca. 15 folds greater than uncoated TCP incubated 
with GM at day 7 and 20 fold higher at day 10. C) Expression analysis of skeletal 
muscle marker myogenin compared to TCP in the differentiation medium. p<0.05 
indicates statistical significance.   
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Figure 3.9 Immunocytochemistry staining of cardiac specific protein, cTnT, and 
cytoskeleton. Confocal images of cTnT staining in H9C2 cells cultured on GAG/K-
PA for 10 days, D) Confocal images of cTnT staining in control TCP group. Green: 
cTnT, red: Actin, blue: nucleus. (Scale bar = 20 µm) 
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Figure 3.10 Characterization of cellular morphology with SEM imaging and confocal 
microscopy. A) SEM image of H9C2 cells incubated in 2% FBS supplemented with 
10 nM RA for 10 days, B) H9C2 cells incubated in growth medium for 10 days kept 
their undifferentiated phenotype. Red=Phalloidin, Blue=ToPro staining. (Scale bar = 
20 μm) 
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           3.4      CONCLUSION 
We aimed to generate a scaffold with both myogenic and angiogenic properties and 
accomplished this through the design of a peptide based bioactive nanofiber system 
that possesses carboxyl, hydroxyl and sulfonate groups to mimic the 
glycosaminoglycan residues found in the myocardium, which play an important role 
in growth factor binding and angiogenesis. In this way, we generated bioactive and 
biodegradable scaffolds to repair damaged myocardium and support vascularization 
after myocardial infarction. Glycosaminoglycan mimetic peptide nanofibers provided 
a biocompatible microenvironment for myoblast cell growth, spreading and 
proliferation. Furthermore, our results showed that H9C2 myoblast cells cultured on 
these nanofibers exhibited differentiation potential towards the cardiomyocyte 
phenotype and expressed the cardiomyocyte-specific marker ventricular myosine 
light chain significantly higher than the control group. Furthermore, the 
differentiation of H9C2 cells into cardiomyocytes was confirmed by the appearance 
of multinucleated cells that stained positive for cTnT, as well as the absence of the 
long myotubes, which are characteristic of skeletal muscle cells. The in vitro studies 
suggested that our heparan sulphate-mimetic bioactive and nanofibrous peptide 
system provides the necessary composition and architecture to support the adhesion, 
proliferation and cardiomyocyte-oriented differentiation of progenitor cells. In 
addition, the in vivo studies performed by our collaborators proved that our peptide 
hydrogels could effectively induce angiogenesis in infarct and periinfarct area after 
myocardial infarction in the rat model. Our results suggest that glycosaminoglycan-
mimetic peptide nanofibers show great potential for cardiovascular tissue 
engineering strategies and offer a promising platform for future clinical applications. 
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An ideal myogenic construct should mimic the morphological, physiological and 
functional properties of the native muscle tissue. Therefore, the development of 
functional myogenic scaffold systems should take into account both the architecture 
and differentiation-enhancing capacities of native tissues, in addition to supporting 
cell adhesion and survival. Self-assembled peptide nanofibers are particularly 
advantageous in this capacity, as they can provide such an environment due to their 
versatile and functional structures. A great variety of peptide structures can be 
designed and synthesized to display desirable structural properties. To demonstrate 
the versatility of peptide-based nanofibers for regenerative medicine, we developed 
two different nanofibrous network systems by self-assembly. In the first study, 
laminin and fibronectin mimetic peptide nanofibers were designed to mimic the 
composition of the basal lamina of skeletal muscle fibers, which plays important 
roles in the migration, growth and differentiation of cells. Laminins in the basal 
lamina enhance the proliferation of myoblasts, stimulate their migration, and lead 
them to assume the bipolar shape characteristic of fusing cells, while fibronectin 
promotes the adhesion and migration of cells. To mimic these proteins, we decorated 
our peptide amphiphiles with IKVAV sequence, derived from the cell binding 
domain of laminin, and RGD cell adhesion sequence, derived from fibronectin. 
These functional groups supported the adhesion and viability of cells, as well as their 
differentiation. Adhesion and viability experiments revealed that laminin-mimetic 
and fibronectin-mimetic peptide nanofibers provide a biocompatible and adaptive 
microenvironment for skeletal myoblast cells’ adhesion, growth and proliferation. 
Moreover, morphological observations revealed that cells cultured on these 
nanofibers fuse with each other and form multinucleated myotubes which were up to 
600 μm length. In addition, laminin mimetic nanofibers exhibited enhanced 
myogenesis and greater expression of myogenic regulatory proteins compared to 
other groups. Immunological stainings of important skeletal muscle protein also 
confirmed the differentiation of cells and formation of long, multinucleated 
myotubes. As a result, this work indicates that our basal lamina mimetic peptide 
nanofiber system provides a favourable microenvironment for myoblast cells to 
grow, differentiate and form long myotubes. Due to the injectible characteristics of 
these nanofibers, they have potential applications in in vivo and clinical studies. To 
achieve this, in vivo muscle damage models could be used to inject peptide 
nanofibers and to evaluate their effect on regeneration of damaged muscle. 
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Furthermore, these systems could be design as a multifunctional for both 
regeneration of damaged tissue and delivery and slow release of drugs to the site of 
injury. If such system is combined with oligonucleotide therapy, it could be 
promising approach for people with muscle degenerative diseases such as muscular 
dystrophy.  
In the second study, we developed glycosaminoglycan-mimetic peptide nanofibers to 
mimic the chemical groups on native glycosaminoglycans in the myocardial ECM, 
which are essential for the maintanence and vascularization of cardiac muscle. It is 
known that these glycosaminoglycans can interact with various growth factors and 
present them to the cell surface receptors to induce angiogenesis, which is important 
to secure the functioning of myocardium after infarction. Carboxyl, hydroxyl and 
sulfonate groups, which are abundant on the heparan sulphate glycosaminoglycans, 
were incorporated into the structure of our peptide amphiphiles to develop a peptide 
nanofiber scaffold that can induce cardiomyocyte differentiation and 
neovascularization for the regeneration of cardiovascular tissue after myocardial 
infarction. In vitro experiments revealed that the microenvironment provided by 
glycosaminoglycan-mimetic peptide nanofibers is biocompatible and conductive to 
the growth and proliferation of cardiac myoblast cells. Both gene expression analyses 
and immunocytochemical stainings supported our findings that myoblast cells were 
differentiated into the cardiomyocyte profile on our peptide amphiphile hydrogels. In 
the in vivo part of this study, glycosaminoglycan-mimetic peptide nanofibers were 
shown to promote neovascularisation by recruiting vascular cells and activating their 
proliferation and maturation. Enhanced neovascularization was found to eventually 
improve cardiac function after MI in rats. Consequently, both in vitro and in vivo 
studies indicate that glycosaminoglycan-mimetic peptide nanofibers offer great 
promise for clinical application and could be used directly or in combination with 
growth factors to rescue ischemic tissue after myocardial infarction.  
Overall, these works offer a general strategy for the development of functional 
myogenic and angiogenic platforms by the bottom-up  design and synthesis of 
molecules that self-assemble into well ordered nanostructures that can be 
functionalized depending on the needs at hand and the application of interest. To 
fully evaluate their efficiency and future succes of our strategy, in vivo studies may 
be performed and later translated into clinical studies. 
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